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Abstract 
The use of synthetic peptides has aroused great interest in tissue engineering field since 
they present several advantages respect to natural source materials such as controlled 
and reproduced chemical composition and molecular weight, the lack of the risk of 
associated infectious diseases, the large-scale production and the possibility to be 
engineered with special functionalities.  
The present PhD Thesis is focused on the fabrication of hybrid scaffolds for bone 
regeneration through biomimetic mineralization of recombinant collagen peptide (RCP) 
in the presence of magnesium ions (Mg) to closely mimic ionic composition of bone 
apatite. RCP sequence is based on human collagen type I and it is enriched in arginine-
glycine-aspartic acid sequence (RGD), that act as a cell binding site.  
The biomimetic mineralization of RCP has been adapted from the bioinspired 
mineralization protocol of natural collagen carried out previously by our group to obtain 
bone-like scaffolds. Inspired in nanocomposite nature of bone, hybrid scaffolds were 
developed through a bottom-up approach that started on the evaluation of apatite 
mineralization mechanism in the presence of RCP and Mg and how they could affect 
the nanocrystal morphology and composition. Then, three-dimensional prototype 
scaffolds were developed through freeze-drying of mineralized RCP slurry to determine 
optimum mineral content. Furthermore, the interfacial properties of mineralized 
matrices in the presence and in the absence of Mg were evaluated at nanoscopic level. 
Since RCP is water-soluble, different crosslinking methodologies (chemical and 
physical) were evaluated to ensure the stability under physiological conditions as well 
as the resistance to enzymatic degradation. The crosslinking of mineralized scaffolds by 
chemical treatment was carried out with a natural crosslinking agent (genipin) by three 
different techniques, named as: pre-crosslinking, post-crosslinking and scaffold 
crosslinking. On the other hand, the physical crosslinking was performed by 
dehydrothermal treatment (DHT). The most suitable crosslinking methodology was 
selected and applied for the following tests. 
The subsequent step was the design of 3D isotropic scaffolds with suitable pore size, 
porosity and permeability by modifying several freezing parameters during freeze-
drying of mineralized RCP slurry. Finally, in vitro tests were carried out to evaluate 
how biochemical signals (i.e., surface chemistry and ion release from scaffold) together 
with biophysical signals (e.g., surface nano-topography) conferred via biomimetic 
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mineralization can persuade and guide Mesenchymal Stem Cells (MSCs) interaction 
and fate. The in vitro study in static conditions revealed a more prominent cell 
migration into inner areas of scaffolds and higher gene expression of osteogenic 
markers for scaffolds mineralized in the presence of magnesium (MgAp/RCP).  
Considering the shortcomings of static cell culture triggering to low extent of cell 
migration towards interior of the scaffold, designed hybrid scaffolds were tested by 
seeding and culturing human mesenchymal stem cells on 3D scaffolds in a bioreactor of 
direct perfusion (developed by Fraunhofer Institute). The results indicated the 
improvement of cell seeding under dynamic conditions, the enhancement of osteogenic 
differentiation for cells cultured on MgAp/RCP scaffolds and the role of mechanical 
stimulus on accelerating the osteogenic differentiation of mesenchymal stem cells. 
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1.1. Introduction: Overview of Bone tissue Engineering Demand 
Bone is a dynamic tissue in continuous process of remodelling consisting in bone 
resorption by osteoclast followed by the bone formation by osteoblast.1 Bone tissue is 
capable to regenerate and heal fracture and defects below a critical size. Nevertheless, 
some pathological conditions such as large traumatic injury, degenerative diseases, 
tumour or bone fragility due to the aging population are still a major challenge in 
common clinical practice which require the use of bone graft for augmenting or 
stimulating the formation of new bone in the defective areas.2,3 The number of 
procedures requiring bone substitutes is increasing worldwide and will continue to do so 
as the population ages is increasing.4 The high importance of this area of tissue 
engineering is evidenced by the 2.2 million bone grafting operations worldwide 
annually, making bone the second most transplanted organs following blood.5  
Autografts, allografts, xenografts and synthetic bone grafts have been used for bone 
augmentation (Table 1). Autografts are taken from another part of the same patient’s 
body, usually trabecular bone from the iliac crest of the pelvis. It is considered as the 
gold standard due to their superior osteogenic potential promoting the proliferation of 
stem cells and their differentiation and holding viable cells that can form new bone 
tissue.5 While immunogenic responses are minimized, their use is limited due to 
elevated fracture rates, donor site morbidity, higher care cost and shortage of supply. As 
alternative, allografts from another donor can allow larger grafts6 but have less efficient 
incorporation and greater potential for immune rejection or pathogen transmission.7,8 
Xenografts (from other specie) carry even greater risk and are not typically considered 
for human bone regeneration.9 To overcome the limited supply of tissue, a variety of 
different materials have been explored to restore bone function and regenerate tissue. 
Artificial bone implants made of metals, ceramics, polymers or composites are 
synthesized and widely used for bone reconstruction and regeneration.10-15 These 
synthesized scaffolds can exhibit satisfactory mechanical properties and 
biocompatibility, as well as other unique properties. However, as compared with bone 
autografts and allografts, there are still some congenital deficiencies, such as ion release 
from metallic scaffolds or low integration of the implant on host tissue, poor strength of  
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polymeric scaffolds,16 friability and brittleness of ceramic scaffolds17 and uncontrollable 
degradability of composites.18   
 
Table 1. Classification of bone grafts and graft substitutes together with their clinical 
evidences. Reprinted from Nandi et al.,19 Copyright (2010), with permission from 
Indian Journal of Medical Research. 
 
Class Description Examples Properties of action 
Autograft 
based 
Used alone  • Osteoconductive 
• Osteoinductive 
• Osteogenic 
Allograft 
based 
Allograft bone used alone or in 
combination with other materials 
Allegro, Orthoblast, 
Grafton 
• Osteoconductive, 
• Osteoinductive 
Factor based  Natural and recombinant growth 
factors used alone or in 
combination with other materials 
TGF-β, PDGF, 
FGF, BMP 
• Osteoinductive 
• Both osteoconductive 
and osteoinductive 
with carrier materials 
Cell based Cell used to generate new tissue 
alone or seeded onto a support 
matrix 
Mesenchymal Stem 
Cells 
• Osteogenic.  
• Both osteogenic and 
osteoconductive with 
carriers materials 
Ceramic based  Includes CaP, calcium sulfate 
and bioactive glass used alone or 
in combination 
Osteograf, 
Osteoset, Novabone 
• Osteoconductive 
• Limited 
osteoinductive when 
mixed with bone 
marrow 
Polymer based Includes degradable and non-
degradable polymers used alone 
and in combination with other 
materials 
Cortoss, OPLA, 
Immix 
• Osteoconductive 
• Bioresorbable in 
degradable polymer 
Miscellaneous Coral HA granules, blocks and 
composite 
ProOsteon • Osteoconductive 
• Bioresorbable 
 
In 1993, the concept of tissue engineering was formally proposed by Langer and 
Vacanti20 as an interdisciplinary field that applies the principles of engineering and the 
life sciences toward the development of biological substitutes that restore, maintain or 
improve tissue function. It consists in isolating cells from the patient, expanding and 
seeding them on synthetic scaffolds and later implant the cell/scaffold construction on 
the defect of the human. The design of a synthetic scaffold is still the core component in 
bone tissue engineering. The ideal synthetic bone graft should imitate the structure and 
properties of natural bone extracellular matrix (ECM), possess a similar macro structure 
to what is found in natural bone, adequate rate of degradation and lack of by-products 
from degradation of the material. On one hand, to enhance osteoinductive properties, 
synthetic scaffolds have been incorporated with bone marrow stem cells,21,22 drugs and 
gene delivery,23 and different growth factors, such as TGF-β,24 BMP25 and VEGF.25,26 
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On the other hand, recent researches have revealed that the specific nanotopography, 
chemistry and nanostructure of biomaterials could not only enhance biocompatibility, 
but also regulate cell/tissue behaviours without the use of growth factors.27-29  
1.2. Bone  
1.2.1. Bone composition and biology 
Bone is a complex cell composite material consisted of a mineralized organic matrix, 
osteogenic cells, extracellular matrix protein (ECM), growth factors and a complex 
vascular system. The main components of bone are the organic matrix (25 wt.%), the 
mineral phase (65 wt.%) and water (10 wt.%).30 The organic phase is mainly constituted 
by collagen type I and non collagenous proteins such as osteonectin, osteocalcin, 
osteopontin, bone morphogenetic proteins, bone proteoglycan and bone sialoprotein 
(less than 10% of the total protein content).31 Bone mineral phase is described as 
hydroxyapatite (HA, Ca10(PO4)6(OH)2) due to mainly elemental composition. 
Nonetheless, bone apatite (Ap) is a non-stoichiometric HA that incorporates foreign 
ions into its structure (i.e., Mg, Sr, Na, CO3) being carbonate (CO3 ≈ 7.4 wt.%) the more 
prevalent anion substitute and magnesium (Mg ≈ 0.7 wt.%) the main cation replacing 
calcium.32 Table 2 summarizes the composition of inorganic phases of adult human 
bone, enamel and dentine.33 
 
Table 2. Elemental composition of the inorganic phases of bone, enamel and dentine of 
adult human. Reprinted from Pina et al.,33 Copyright (2015), with permission from 
WILEY-VCH Verlag GmbH & Co: Advanced Materials. 
 
Composition (wt.%) Bone Enamel Dentin 
Calcium (Ca) 34.8 36.5 35.1 
Phosphorous (P) 15.2 17.7 16.9 
Sodium (Na)  0.9 0.50 0.60 
Magnesium (Mg) 0.72 0.44 1.23 
Potassium (K)  0.03 0.08 0.05 
Zinc (Zn) 0.0126-0.0217 - - 
Fluoride 0.03 0.01 0.06 
Chloride (Cl) 0.13 0.30 0.01 
Carbonates  7.4 3.5 5.6 
 
 
The main peculiarity of bone is that it is a dynamic hard tissue that undergoes a 
continuous remodelling to maintain skeletal strength and integrity, with 10% of the 
skeleton being replaced annually. Figure 1 illustrates bone-remodelling process in 
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which haematopoietic stem cell (HSC)-derived osteoclasts resorb bone releasing growth 
factors and calcium whereas mesenchymal stem cell (MSC)-derived osteoblasts replace 
the voids with new bone. The remodelling process is regulated by osteoblast 
commitment, proliferation and differentiation coupled with osteoblast production of 
type I collagen and its subsequent mineralization to form the calcified matrix of bone. It 
has been proposed that osteocytes, which are terminally differentiated osteoblasts that 
are embedded in bone, act as a biological “strain gauges” that respond to change in 
mechanical pressure and send chemical or electrochemical signals that activate 
osteoclasts and osteoblast.34 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Scheme of bone remodelling. Reprinted from Weilbaecher et al.,34 Copyright 
( 2011) with permission of Nature Publishing Group: Nature Reviews Cancer. 
 
1.2.2. Hierarchical structure of bone 
Bone is a complex hierarchical structure composed of several levels (Figure 2).31 At the 
macroscopic level, a typical human long bone is generally composed of the cortical 
bone, the cancellous bone, the periosteum, the endosteum and the articular cartilage. 
The cortical bone, comprising 80% of the bone mass, is a compact layer surrounding the 
central marrow cavity exhibiting a high Young’s modulus value and therefore, 
providing the sufficient mechanical strength to bear weight. On the other hand, 
cancellous bone (around 20% of the total mass of the skeleton) has an open, honeycomb 
structure and it is able to dampen the sudden stress. The cartilage is a type of collagen-
based connective tissue composed of very large protein–polysaccharide molecules that 
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provide a tough and flexible matrix. The periosteum, which is found on the surface of 
the medullary cavity, is a fibrous membrane of connective tissue rich in fibroblasts and 
progenitor cells that are critical for the formation of new bone. The endosteum is a thin 
layer of lining cells with relevance during the process of bone remodelling.4 
 
 
 
 
 
 
 
 
Figure 2. Hierarchical structure of bone. Reprinted from Wang et al.,35 Copyright 
(2016) with permission of Elsevier: Biomaterials. 
 
The nanoscopic level of bone belongs to collagen molecules. There are twenty-eight 
different types of collagen composed of at least 46 distinct polypeptides.36 Among 
them, type I collagen is the main organic constituent of bone and consists in two α1 and 
one α2 peptide chains that comprise a repeating glycine (Gly)-X-Y triplet, in which X 
and Y can be a residue but are usually proline (Pro) and hydroxyproline (Hyp), 
respectively. The three polypeptide strands are held together in a helical conformation, 
the tropocollagen triple helix which is described as a long thin semi-rigid rod about 300 
nm in length and 1.5 nm in diameter.37 They join together with other tropocollagen 
molecules in a quasi-hexagonal unit cell containing five tropocollagen monomers (i.e., 
collagen microfiber) exhibiting a typical D-banding pattern of 67 nm,37-39 consisted of 
two zones, the hole zone (40 nm) and the overlap zone (27 nm). Bone apatite 
crystallization takes place inside the hole zone (the process is described in the 
forthcoming section). The collagen microfibrils crosslink into collagen fibre with a 
diameter lower than 500 nm and a length lower than 1 cm.37 Mineralized collagen fibrils 
mostly present in bundles or arrays aligned along their lengths. These bundles are, 
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however, not discrete. Fibres from one bundle may fuse with a neighbouring bundle 
prompting to fibril arrays that organized in a variety of patterns forming sheets. In the 
case of bone, the sheets are assembled with bone cells (osteocytes) that reside between 
adjacent layers, and together these are either stacked in parallel arrays (lamellar bone) 
or concentrically arranged into a cylindrical structure referred to as the osteon.	Osteons 
are formed with significant cellular activity and remodelling; osteoclasts resorb bone 
and form a tunnel, and osteoblasts subsequently lay down lamellae in stacked layers 
until only a small channel (Haversian canal) is left behind. These channels serve as a 
conduit for nerves and blood supply whereas small channels (canaliculi), which are 
interconnected in the marrow cavity, provide microcirculation of blood and nutrients to 
the cells.30 
1.2.3. Bone biomineralization 
In organism, biomineralization offers structural support and mechanical strength as well 
as a wide variety of important biological function such as protection, motion, cutting 
and grinding, buoyancy, optical, magnetic and gravity sensing or storage.40 These 
properties rely on the complex structure of biominerals which results from biologically 
controlled mineralization that involves the specialized regulation of mineral deposition 
and results in functional materials with specific crystallochemical properties such as 
uniform particle sizes, well-defined structures and compositions, high levels of spatial 
organization, complex morphologies, controlled aggregation and texture, preferential 
crystallographic orientation and higher-order assembly into hierarchical structures.40 
Early studies on bone formation have been able to establish the spatial and 
crystallographic relationship between collagen and the bone apatite (Ap). Conventional 
transmission electron microscopy (TEM) studies, combined with X-ray and electron 
diffraction have shown that the Ap crystals nucleate and grow within the 40 nm gaps 
present in the collagen fibril, and have their c-axis aligned parallel to the long axis of 
collagen fibres (Figure 3).31,41-43 Bone apatites are plate-shaped with a length between 
30-50 nm, a width of 20-25 nm and a thickness of 1.5-4 nm.44,45 It is still unclear how 
the final Ap crystallites form within the collagen fibrils with plate-shape morphology 
and what is the role of the collagen matrix and the non-collagenous proteins (NCPs) on 
this process.  
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Figure 3. Nanoscopic view of mineralized collagen fibre structure and organization. (a) 
Model of mineralized collagen fibrils showing the arrays of the plate-like Ap 
nanocrystals in the gap zones formed in staggered arranged collagen fibrils. (b) Face-on 
and edge-on projections of the crystals in the mineralized fibril. (c) TEM micrograph of 
an array of the mineralized fibrils from human dentin. Reprinted from Beniash et al.,46 
Copyright (2011) with permission from John Wiley & Sons, Inc: Wiley 
Interdisciplinary Reviews, Nanomedicine and Nanobiotechnology. 
 
Bone apatite nucleation and growth requires a local environment with sufficient 
supersaturation in the mineral precursors. Two main modes have been proposed: a) 
calcium phosphate (CaP) first nucleates within the matrix vesicle membrane during 
phase 1 of biologic mineralization and then the phase 2 of biologic mineralization 
begins with the breakdown of matrix vesicles membranes, exposing the CaP mineral to 
the extracellular fluid47-49 and b) the CaP crystals are actively nucleated from solution 
by the NCPs associated to the collagen gap zones, without intervention of cellular 
processes.41,50 A large area of biomineralization research is focused on the role of NCPs, 
including bone sialoprotein (BSP), osteonectin (ON), osteopontin (OPN) and 
osteocalcin (OCN).51,52 The primary amino acid sequence of these proteins often 
includes a high density of aspartic acid and glutamic acid residues, which have a high 
affinity for calcium ions.53 Anionic polypeptides like polyaspartic acid (pAsp)30,54,55 and 
fetuin56,57 that mimic the polyanionic character of the NCPs have been used to achieve 
in vitro collagen mineralization by means of polymer-induced liquid precursor phase.30 
It has been proposed that the fluidic character of the amorphous precursor phase (ACP) 
allows the penetration of ACP into the 40 nm nanoscopic gaps in the collagen fibrils by 
capillary action, thereby facilitating the intrafibrillar mineralization of collagen fibres. 
Since the ACP-pAsp complex is negatively charged, the most favourable entry sites in 
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the collagen should be the ones with the highest positive charge and therefore the lowest 
electrostatic potential energy to interact with the complex, which was indeed observed 
experimentally.54 On the other hand, a recent work demonstrated the clear role of the 
collagen matrix in directing the morphology and orientation of the Ap nanocrystals 
without the presence of additives. It was shown that collagen molecules also got 
infiltrated with Ap nanocrystals by simply using reaction solutions containing very high 
concentrations of calcium and phosphate ions58 in the absence of any type of additive 
mimicking the working of NCPs. The in vivo bone mineralization mechanism still 
remains unclear though.  
1.3. Biomaterials for bone regeneration inspired in bone biomineralization  
In the last decades, scientists have tried to learn from nature how to design biomimetic 
biomaterials inspired by the hierarchical complex structure of bone and other natural 
mineralized tissues. The design of nanocomposites, that recapitulate the organization of 
natural bone ECM, has certainly constituted a major breakthrough in bone tissue 
engineering. Considering that in nature, macromolecular frameworks in the form of an 
organic matrix are commonly used to control biomineralization (crystal nucleation and 
growth) in extracellular sites, a wide range of biomaterials for bone regeneration have 
been developed by bioinspired mineralization of natural or synthetic polymers, proteins 
and/or peptides. 
1.3.1. Design of biomaterials via biomimetic mineralization of natural polymers  
The development of nanocomposite scaffolds has been inspired on natural 
biomineralization processes that drive the formation of new bone in mammals. Organic 
macromolecules such as natural polymers (i.e., collagen, cellulose, chitosan, gelatin, 
alginate and fibroin) have been used as template/matrix to develop nanocomposite 
scaffolds via biomimetic mineralization. The main advantage concerning the use of 
natural polymers is the possibility to be extracted in massive amounts from a number of 
sources (including waste products) representing a nearly unlimited, safe, cheap and 
environment-friendly source of raw materials. For instance, bio-inspired mineralization 
of natural collagen (e.g., collagen extracted from horse tendon) has been extensively 
applied for the development of advanced biomaterials for bone regeneration. The 
process enables the activation of various mechanisms driving the assembling, 
organization and mineralization of natural collagen thus generating hybrid fibrous 
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materials having compositional and morphological features similar to those of newly 
formed bone.22,59,60 Denatured collagen, gelatin, has been also used as organic matrix 
for bone tissue engineering.61-63 Gelatin is free of immunogenic concerns and contains 
integrin binding sites which are important for cell adhesion.64 Porous scaffolds made of 
gelatin-HA and obtained through biomimetic precipitation method have been also 
proposed for bone tissue regeneration.61 Other natural polymers such as chitosan and 
silk are especially known for their excellent mechanical properties.65,66 Hence, 
nanocomposite HA/chitosan scaffolds with compositional and structural features close 
to natural bone ECM, have been shown to support bone marrow-derived mesenchymal 
stromal cell (BMSC) adhesion, spreading and promotion as well as induce their 
osteogenic differentiation in vitro and in vivo.65  
Nevertheless, the use of natural polymers might present some limitations such as 
thermal instability, possible contamination with pathogenic substances and/or low 
possibility to introduce specific sequence modifications to enhance scaffold 
biofunctionality.  
1.3.2. Biomimetic mineralization of synthetic polymers  
To overcome the above-mentioned shortcomings, material scientists have explored the 
use of synthetic polymers for bone regeneration since they can be produced in large 
uniform quantities and have a long self-time. Moreover, synthetic polymers are highly 
useful in biomedical field since their properties (i.e., porosity, degradation time and 
mechanical characteristics) can be tailored for specific applications.67 In bone 
regeneration field, the development of composite materials consisting of synthetic 
polymers and calcium phosphate minerals (CaP) has attracted a great attention owing to 
their wide range of unique properties, particularly in terms of their ability to emulate the 
soft/hard composite structure of bone. The synergistic role of polymers providing 
viscoelastic properties and CaP promoting osteoconductivity of designed scaffolds has 
yielded materials that surpassed the resistance to fracture, structural integrity and 
stiffness of the individual components, making up for the low compressive strength of 
the former and brittleness and the lack of malleability of the latter.68 Synthetic polymers 
used on biomedical field can be divided in two main groups: biodegradable and non-
biodegradable. Composites for bone regeneration have been developed by incorporation 
of CaP in non-biodegradable polymers such as polysiloxanes,69 poly(methyl 
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methacrylate)70 and other acrylics,71 polyethylene72 and polypropylene73 among olefins 
and poly(vinyl alcohol)74 among haloalkanes. Biodegradable polymers used in 
combination with CaP include poly(L-lactic acid, PLLA),75 poly(lactic-co-glucolic acid, 
PLGA),76 poly(ε-caprolactone)77,78 various polyanhydrides and some of the more rarely 
used polymers, counting poly-p-dioxanone,79 poly(trimethylene carbonate)80 and many 
others.  
1.3.3. Self-assembly and mineralization of synthetic peptides  
Last decades, there has been an increasing interest in the use of synthetic peptides as 
bioactive matrices for regenerative medicine promoting the interactions with cells and 
eliciting desired behaviours in vivo.81 The synthetic peptides can be designed at 
molecular level to self-assemble and create supramolecular nanostructures that mimics 
ECM. Among them, peptide amphiphiles (PA) have been extensively studied as matrix 
for regenerative medicine.82-86 The group of Stupp et al.85 investigated the self-assembly 
and mineralization of PA nanofibers containing RGD sequences at controlled 
concentrations and phosphorylated serine residues to template hydroxyapatite. The 
mineralized PA nanofibers appeared to promote osteogenic differentiation of 
mesenchymal stem cells (MSCs), based on alkaline phosphatase and osteopontin 
expression of hMSCs cultured on PA gels.86  
1.3.4. Bio-inspired self-assembled and mineralization of recombinant proteins  
Other alternative to the biopolymers is the recombinant protein expression system.87 
Recombinant proteins present several benefits such as controlled and reproduced 
chemical composition and molecular weight avoiding the risk of associated infectious 
diseases as in the case of biopolymers and the possibility to be produced at large-scale. 
There are several systems for protein expression. For instance, some works have 
described the production of recombinant gelatin-like proteins in Escherichia coli. Alike 
to the natural amino acid sequence of collagen triple-helix forming domain, synthetic 
genes are constructed from repeating (Gly-Xaa-Yaa)n-encoding oligonuleotides, where 
Xaa and Ya are often proline.87-89 Conversely, expression levels usually obtained in 
E.coli were rather low and the purification of the intracellular produced protein can be 
difficult. Therefore, several authors focused on the expression of high levels of type I 
homotrimer and heterotrimer and type II and type III collagen by yeast. As example, 
recombinant gelatin has been expressed in yeast such as Pichia pastoris40,90,91 in both 
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non-hydroxylated and hydroxylated forms. On the other hand, other systems such as 
mammalian and insect cells, transgenic tobacco plants, transgenic mice, transgenic 
silkworm have been engineered to produce recombinant collagen molecules.92  
Fujifilm Europe B.V. has developed a technology to produce recombinant collagen 
peptide (RCP) through a yeast-based fermentation process. Like traditional collagen and 
gelatin, RCP consists of the characteristic collagen triplet amino acid base structure 
(Gly-X-Y). Moreover, the DNA technique allows adjustment of the amino acid 
sequence of the RCP. Special functionalities can easily be added, such as additional cell 
binding sites (arginine-glycine-aspartic acid sequences, RGD) or increased number of 
(electrical charging) amines. RGD sequence is found in cell adhesive proteins like 
vitronectin, laminin, and fibronectin and is recognized by the cell’s transmembrane 
integrin receptors that tether the cell cytoskeleton to the fibre of ECM, forming local 
focal adhesion. RGD has demonstrated in vitro regulation of cell adhesion and 
differentiation, and more importantly, enhancements in in vivo responses, including 
bone formation and integration.93 For instance, in vivo studies indicated that 
microspheres produced with human recombinant gelatin containing RGD sequences are 
faster infiltrated by cells, display a faster degradation profile and shows a rapidly stroma 
formation compare with microsphere developed with usual recombinant gelatin 
(without RGD sequences).94 This material has been also explored as a vehicle to 
delivery cells (ADCs)95 and as a promising controlled release system of BMP-2.96 
Few studies on the mineralization potential of recombinant human like collagen 
(RHLC) have been carried out until now.97-99 For instance, Wang et al. studied 
mineralization of RHLC as an initial stage on the use of mineralized RHLC for bone 
tissue engineering.99 They indicated that RHLC prefers to chelate calcium ions in 
solution and so subsequently regulates the mineralization forces to obtain RHLC-HA 
composites. Furthermore, they have evaluated the osteoinductive potential of porous 
scaffolds made of poly-lactic acid and mineralized recombinant-human collagen non-
loaded100 and loaded with synthetic BMP-2-derived peptide.101 
Despite the recent studies on the development of nanocomposite materials for bone 
regeneration through biomineralization of recombinant peptides, engineering of 3D 
scaffold structures to ensure cell integration and their differentiation to osteogenic 
linage remains still in its infancy.  
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1.4. Scaffold design for bone tissue engineering 
Scaffold design and fabrication for bone tissue engineering should accomplish several 
requirements: three-dimensional and highly porous structure with an interconnected 
pore network and surface properties which promote cell-biomaterial interactions, cell 
adhesion and ECM deposition; be biocompatible, not elicit an immune response; be 
biodegradable with a controllable degradation rate to compliment cell/tissue in-growth 
and maturation; its mechanical properties should match those of the tissue at the site of 
implantation; provoke a minimal degree of inflammation or toxicity in vivo and the 
scaffold structure should be easily and efficiently reproducible in various shapes and 
sizes.16,102 Furthermore, scaffolds should be osteoconductive, osteoinductive and 
promote osseointegration in vivo. To match all or majority of this function, a thorough 
understanding of the chemistry and physicochemical properties of the tissue to be 
engineered and the materials used in this process is required.  
1.4.1. Biocompatibility 
Biocompatibility represents the ability of a material to perform an appropriate response 
with respect to a specific medical application, without eliciting an immune response. 
One of the major concerns is the release of by-products that may be biocompatible 
without proof of elimination from the body (biodegradable scaffolds) or can be 
eliminated through natural pathways from the body, either by simple filtration of by-
products or after their metabolization (bioresorbable scaffolds).16 The capacity of the 
surrounding tissue to eliminate the by-products may be low due to poor vascularization 
or low metabolic activity, leading to a build up of the by-products thereby causing local 
temporary disturbances. For instance, polylactide scaffolds promote a decrease of local 
pH leading to inflammatory reactions.103 
1.4.2. Degradation kinetics 
The ideal scaffolds should be bioresorbable and degrade under physiological 
environments by the surrounding tissues in order to allow the ultimate replacement of 
scaffold material with newly formed bone without the need for surgical removal. In 
order to obtain a desired and controllable biodegradation rate for practical application, 
the scaffold design should consider the chemical composition and structure of bulk 
materials, as well as the properties of coatings and the specific biological environment. 
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For instance, hybrids/composites comprising different kinds of polymers or 
polymer/ceramic/bioglass can enhance mechanical properties, biological functions and 
simultaneously can modulate their biodegradation behaviour.15,104-106 Furthermore, 
ECM-derived biomolecules are accessible to surface erosion due to their high enzymatic 
sensitivity, which induces the rapid degradation of scaffolds made from these materials, 
like chitosan, collagen and gelatin.15,105,107,108	 The incorporation of inorganic 
nanoparticles, the addition of dual organic components or the crosslinking of the 
organic components allow the control of their degradation rate.105,109,110 
In bone tissue engineering, the degradation and resorption kinetics of the scaffold have 
to be controlled in such a way that the bioresorbable scaffold retains its physical 
properties for at least 6 months to enable cell and tissue remodelling.16 Among 
difference anatomical and physiological variables, the type of tissue that is aimed to be 
engineered has a profound influence on the degree of remodelling since the remodelling 
in cancellous bone takes 3-6 months while it takes twice as long, approximately 6-12 
months, in the case of cortical bone.111  
1.4.3. Mechanical properties 
For bone regeneration, the mechanical properties of a biomaterial are critical to the 
success of the implant and depend on the tissue into which they are implanted. The 
scaffold is responsible for (temporal) mechanical support and stability at the tissue-
engineering site until the new bone is fully matured. Therefore it is critical that the 
scaffold temporally withstands and conducts the loads and stresses that the new tissue 
will ultimately bear. The scaffold should resist changes in shape resulting from the 
introduction of cells into the scaffold (each of which should capable of exerting 
tractional forces) and from wound contraction forces that would be evoked during tissue 
healing in vivo.111 The mechanical properties of bulk biomaterials are altered by their 
processing into scaffolds of various pore sizes and pore orientations,5 the crosslinking 
methodology of the organic matrix112,113 or by combining several materials (polymers, 
ceramics and metals). 
1.4.4. Surface properties 
The ideal scaffolds should mimic the natural extracellular matrix (ECM) as much as 
possible, since the ECM found in natural tissues supports cell attachment, proliferation, 
and differentiation. The scaffolds should consist of appropriate biochemistry and 
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nano/micro-scale surface topographies, in order to formulate favourable binding sites to 
actively regulate and control cell and tissue behaviour, while interacting with host cells.  
Certain	surface features can facilitate the adsorption of cell-adhesive proteins and thus 
provide conditions for the formation of stable focal adhesive complexes.10 The bioactive 
surfaces of nanomaterials (Figure 4) mimicking those of natural bones promote greater 
amounts of protein adsorption and efficiently stimulate more new bone formation than 
conventional materials.114 
 
 
 
 
 
 
 
 
 
Figure 4. Schematic illustration of the mechanism by which nanomaterial surface 
properties may be superior to conventional materials for bone regeneration. Reprinted 
from Zhang et al.,114 Copyright (2009) with permission of Elsevier: Nanotoday. 
 
 A wide variety of techniques have been implemented in order to functionalize material 
surface with the aim of enhancing the biofunctionality and bioactivity of already used 
synthetic scaffolds such as metallic implants (titanium) or synthetic polymer scaffolds 
(i.e. PLLA, PCL, PLGA). They can be divided in two groups according to Wu et al.:4 
surface functionalized chemistry and surface functionalized structure. The former is 
subdivided in several subgroups: coating with calcium phosphate mineral (bioactive 
component), ECM proteins or even hybrid coatings (comprised of biomolecules and 
calcium phosphate), inducing biomineralization by soaking in simulated body fluid 
(SBF) and surface polymerization (i.e., aminolysis, hydrolysis, electron beam radiation 
or plasma polymerization). On the other hand, surface structure (topographies, 
roughness and nano-architectures) can be modified via chemical (i.e., anodization, 
hydrolysis, chemical vapour diffusion, sol-gel or biomineralization) and physical 
treatment (i.e., plasma spraying, magnetron sputtering or inert-ion texturization) in 
order to carter especially to particular biological applications. Engineering surface by 
combining both, chemistry and structural functionalization will provide exceptional 
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scaffold interfacial properties. For instance, the calcium phosphate coating of scaffold 
will allow to tailor both, topography (depending on coating parameters) and chemistry 
by ions substitution on crystal lattice (Sr, Mg or CO3) or functionalization of mineral 
surface (incorporation of proteins or drugs115).4  
1.4.5. Scaffold microstructure 
Scaffold microstructure (porosity, pore size, pore shape and interconnectivity) will 
dictate the surface area available for the adhesion and growth of cells both in vitro as 
well as in vivo. The porosity is associated to the free available space (void volume of a 
solid) for cell penetration and tissue ingrowth. The porosity of a biomaterial can be 
modulated through different techniques such as salt leaching, gas foaming, phase 
separation, freeze-drying and sintering. It can be measured by different techniques (e.g., 
mercury intrusion porosimetry, gravimetry method, liquid displacement and micro-CT). 
Scaffolds made of PLL and β-tricalcium phosphate with porosity gradient and 
controlled pore size showed a more tissue ingrowth and new bone formation in the areas 
of higher porosity after implantation in rabbit craniums.116 However, it is hard to 
directly link the scaffold porosity to cell performance. Although increased porosity and 
higher pore size facilitate bone ingrowth, it also compromises the structural integrity of 
the scaffold, and if the porosity becomes too high it may adversely affect the 
mechanical properties and the degradation kinetics of the scaffold at the same time.111 
The effect of pore size and pore interconnectivity on bone tissue regeneration has been 
explored by many researches along the last decades. Small pores favour hypoxic 
conditions and induce osteochondral formation before osteogenesis occurs.117 The 
optimum pore size for bone regeneration has been indicated between 200–350 µm. 
118,119 Pore interconnectivity is also critical to provide mass transfer of oxygen and 
nutrients.3,120 In fact, pore interconnections smaller than 100 µm were found to restrict 
vascular penetration.16 
Pore interconnectivity and tortuosity will affect the scaffold permeability that 
simultaneously will influence the gas and liquid transport inside scaffolds. For bone 
regeneration, especially for the repair of large-scale defects, sufficient nutrients need to 
be delivered into the inner pores to support cell survival. Greater scaffold permeability 
has been shown to promote bone penetration and vascularization in vivo.121  
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1.4.6. Osteoconduction, osteoinduction and osseointegration 
As we mentioned before, scaffolds should be osteoconductive, osteoinductive and imply 
osseointegration.122 Osteoinduction is the recruitment and stimulation of 
undifferentiated, pluripotent cells to differentiate in bone-forming cells (preosteoblasts, 
osteoblasts, and finally osteocytes). There are several genes and proteins involved in the 
osteogenic differentiation and they are commonly used as markers of the osteoblastic 
phenotype (Table 3). Osteoinductive potential of scaffolds has been tested by analysing 
the new bone formation after injection of the scaffold into an ectopic bed. 
Osteoconduction refers to the property of the material to support the growth of new 
bone on its surface or down into pores or channels. After a trauma, this growth can 
occur by existing preosteoblasts and osteoblasts or by differentiation into these cells 
(osteoinduction). The process of osteoconduction depends on the nature of the material 
as well as the presence of certain growth factors and the sufficient vascularization. 
Respect to osseointegration, it represents the direct, microscopic contact between living 
bone and an implant material. It has been histologically defined as the direct anchorage 
of an implant by the formation of bony tissue around the implant without the growth of 
fibrous tissue at the bone implant interface. 
Table 3. Common markers of osteogenic differentiation. Reprinted from Samavedi et 
al.,10 Copyright (2013), with permission from Elsevier: Acta Biomaterialia. 
 
Name Type Primary function during differentiation 
Runx2 Transcription factor • Helps in the differentiation of MSCs into 
immature osteoblasts 
Osterix Transcription factor • Acts downstream of Runx2 and promotes 
osteogenesis 
Alkaline Phosphatase (ALP)  Enzyme • Increases local concentration of phosphate 
ions that in turn initiate mineral growth 
Type I Collagen ECM protein • Mineral nucleation begins at the junction 
between two collagen fiber bundles 
Osteopontin (OPN)  ECM protein  • Acts as an inhibitor towards irregular 
formation of mineral crystals 
Bone sialoprotein (BSP) ECM protein • Binds to Ca2+ via free hydroxyl groups and 
promotes nucleation of mineral 
Osteocalcin (OCN) ECM protein • Regulates mineral growth, direction, size and 
quantity during late stages  
Osteonectin (ONN) ECM protein • Similar role to that played by osteocalcin 
Bone morphogenic protein 2 
(BMP2)  
Growth factor • Secreted by immature osteoblasts  
Bone morphogenic protein 7 
(BMP7) 
Growth factor • Similar role to that played by BMP2 
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Chapter 2: General Experimental Methods and Techniques 
2.1. Materials 
Recombinant collagen peptide (RCP) is commercialized by Fujifilm Manufacturing 
Europe B.V. under the tradename CellnestTM. It is defined as a recombinant peptide 
based on human type I collagen (α1 chain). It has a molecular weight of approximately 
51 kDa and an isoelectric point of 10.  
 
 
 
 
 
 
Figure 1. Recombinant collagen peptide (RCP) amino acid sequence is based on human 
collagen type I. 
Phosphoric acid (H3PO4, purity ≥ 85 wt.%), calcium hydroxide (Ca(OH)2, purity ≥ 
95%) and magnesium chloride hexahydrate (MgCl2·6H2O, ≥ 99% purity) were 
purchased from Sigma Aldrich. The solutions were prepared with ultrapure water (0.22 
µS, 25 °C, MilliQ©, Millipore). Genipin was purchased from Wako Pure Chemical USA 
(purity 98% HPLC). 
2.2. Characterization techniques 
Ø X-Ray Diffraction (XRD) spectra were obtained by using a Cu Kα radiation at a 
wavelength of 1.5418 Å on a PANalytical X’Pert PRO diffractometer equipped with a 
PIXcel detector operating at 40 mA and 45 kV. The XRD spectra were acquired in the 
2θ range 4°-100°, with a step size of 0.013° and scan time of 1900 s. The average 
crystallite size along the apatite axis directions [002] and [310] was calculated by 
applying the Scherrer equation:  
𝑡 = 𝐾λ 𝛽! ! cos𝜃        (1) 
where t is the average of crystallite size in Å, K is the shape factor (fixed at 0.9 for 
spherical crystallites), λ is the wavelength of Cu Kα radiation (1.5418 Å) and 𝛽! ! is the 
full width at half-maximum intensity.  
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Ø Fourier transform infrared (FTIR) spectra of synthesized samples were collected 
by Nicolect 380 FTIR spectrometer (Thermo Fisher Scientific, Waltham, MA). 5 mg of 
sample was mixed with ~250 mg of anhydrous potassium bromide (KBr). The mixture 
was pressed at 10 tons pressure into 7 mm diameter disc. A pure KBr disk was used as 
background. The spectra were registered from 4000 cm-1 to 400 cm-1 with a resolution 
of 2 cm-1.  
 
Ø Raman spectra were collected with a LabRAM-HR spectrometer with 
backscattering geometry (Jobin-Yvon, Horiba, Japan). The excitation line was provided 
by a diode laser emitting at a wavelength of 532 nm and a Peltier cooled charge-couple 
device (CCD) (1064x256 pixels) was used as detector. Spectrometer resolution is higher 
than 3 cm-1. The final spectrum resulted by the average of 3 acquisitions (acquisition 
time= 300 s). Curve fitting, using Lorentzian functions, and quantification of integral 
areas was done using MagicPlotPro (2.5.1) software.  
 
Ø Transmission Electron Microscopy (TEM) evaluation was performed with FEI 
Tecnai F20 microscope operating at 120 kV. Samples were prepared directly from the 
solution after 2 hours of mineralization. 10 µL aliquot was diluted 1:1000 in ultrapure 
water and sonicated for 15 min. Diluted samples were deposited on 200 mesh copper 
TEM grids covered with thin amorphous carbon films and incubated for several 
minutes. After that, the grids were rinsed with ultrapure water, being then the water 
excess manually blotted. 
 
Ø Inductively-coupled plasma optical emission spectrometry (ICP-OES, Agilent 
Technologies 5100) was employed to analyse the chemical composition of synthesized 
samples (Ca, P, Mg). For this analysis, 20 mg of sample were dissolved in 2 ml of 
ultrapure nitric acid and then diluted up to 100 mL. Diluted solutions were analysed for 
analytical emission wavelengths: Ca (422 nm), Mg (279 nm) and P (214 nm).  
 
Ø Thermogravimetry analysis (TGA) of the designed matrices was carried out in a 
simultaneous thermal analyzer (STA 449 Jupiter Netzsch Geratebau). About 10 mg of 
sample were weighted in a platinum crucible and heated from room temperature to 1000 
°C under airflow with a heating rate of 10 °C/min.  
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Ø Brunauer-Emmett-Teller (BET) gas adsorption method (Sorpty 1750, Carlo Erba, 
Milan Italy) was used to measure the specific surface area (SSA) of powdered samples. 
 
Ø Scanning electron microscopy (ESEM FEI Quanta 200, Oregon, USA) was used to 
analyse mineral distribution and the pore size of scaffold prototype, the hybrid matrices 
and 3D scaffolds. Samples were fixed on aluminium stubs using a carbon tape and 
sputter with a 20 nm thick gold layer. SEM images were acquired at 10 KeV at high 
vacuum.  
2.3. Characterization of the physic-chemical properties of designed scaffolds  
2.3.1. Porosity and pore size 
Total porosity was measured by gravimetry according to the following equation: 
𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 % = 100 · 1− !!"#$$%&'!!"#$%&"'     (2) 
,where ρmaterial is the density of the material of which the scaffold is fabricated and 
ρscaffold is the apparent density of the scaffold measured by dividing the weight by the 
volume of the scaffold.1 Density of RCP is consider 1.3 g/cm3 according to technical 
specification and apatite density is consider 3.16 g/cm3 according to the literature.2 
The mean pore size of RCP, Ap/RCP and MgAp/RCP scaffolds was obtained by 
measuring 60 pores from SEM micrographs with Image J software (version 1.48v, NIH, 
Bethesda, Maryland). 
2.3.2. Permeability 
The scaffold permeability was evaluated by falling head method. It consists in 
measuring the time that a fluid column drop from the upper (H1) to the lower level (H2) 
of a standpipe while fluid flows through the scaffold, which is hosted to a permeability 
chamber that directly connects to the standpipe. Five scaffolds per condition were 
autoclaved in phosphate buffered saline (PBS) and maintained in PBS solution 
overnight (37 °C) before the measurements. The scaffold permeability constant was 
calculated according to Darcy’s law:3  
𝑘 = !! !! !!" 𝑙𝑛 !!!!     (3) 
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Where: k, scaffold permeability (m2); a, cross-sectional area of standpipe (mm2) 𝑎 = 𝜋𝑟!!; A, cross-sectional area of scaffold (mm2) 𝐴 = 𝜋𝑟!!; L, scaffold thickness 
(m); t, time for PBS going from H1 to H2 (s); H1, H2, height of PBS column (cm); µ, 
dynamic viscosity of fluid (Nsm-2); ρ, density of fluid (kg/m3) and g gravity (m/s2). 
2.3.3. Interfacial properties: Surface roughness and wettability 
Atomic Force Microscopy (AFM) images were acquired with a Multimode-Nanoscope 
3D (Digital Instruments, Bruker Nanosurface division, USA), equipped with an E 
scanner, using SNL-10 probes (Bruker AFM Probes) with 250 µm of length and 40 µm 
of width (with 23 kHz nominal resonant frequency and 0.12 N/m nominal spring 
constant). Imaging was performed in air condition and contact mode. Surface roughness 
has been characterized in terms of root mean square (RMS) roughness (Rq) that belongs 
to the average between the height deviations (Z) and the mean/line surface, taken over 
the evaluation length/area: 𝑅! = !! 𝑍! −  𝑍 !!!!!                                                   (4) 
The scan length and the resolution of the measurement were kept constant in order to 
decrease the influence of the scanning parameters on roughness value. The roughness 
was calculated for two scan areas of 2.5 x 2.5 µm2 and 5 x 5 µm2 with a fixed resolution 
of 512 x 512 points.  
Wettability of designed matrices was evaluated by measuring contact angle in an optical 
tensiometer equipped with a CCD camera (OCA 15 Plus, DataPhysic Instruments). 
Measurements were carried out in static condition with the sessile drop method (drop 
volume of 1 µl of water). 
2.3.4. Swelling capacity 
Swelling capacity of the scaffolds was evaluated by introduction of scaffolds into 
phosphate buffered solution (PBS, pH 7.4) at 37 °C with gentle shaking. After 24 hours, 
scaffolds were removed, wiped with filter paper to remove excess of liquid and weight 
(Ww). Swelling capacity was determined according to next equation: 𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 (%) = 100!!!!!!!                                   (5) 
, where Wd is the initial dry weight of scaffolds before immersion into PBS. 
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2.3.5. Determination of extent of crosslinking 
TNBS assay was used to determine the primary amine content in recombinant collagen 
peptide and quantify the crosslinking degree of processed recombinant collagen 
scaffolds. Through this protocol, the content of amino groups can be identified by 
labelling with 2,4,6-trinitrobenzenesulfonic acid (TNBS). Both crosslinked (C) and non-
crosslinked (NC) scaffolds were immersed in 2 mL of solution containing 1 ml of 
sodium bicarbonate solution (4% w/v) and 1 mL TNBS solution (0.5 %) and incubated 
at 37 °C for 3 hours in a water bath with shaking. After that, 3 mL of hydrochloric acid 
(pure) was added to mask the unreacted TNBS. The volume was raised to 10 mL and 
the solution was kept for 15 hours in a water bath at 37 °C. The absorbance of the 
diluted solutions was measured at 345 nm using UV-vis Spectrophotometer and 
crosslinking degree was calculated by the following equation: 
𝐶𝑟𝑜𝑠𝑠𝑙𝑖𝑛𝑘𝑖𝑛𝑔 𝑑𝑒𝑔𝑟𝑒𝑒 % = 100 · !"#!"!!"#!!"#!"      (6) 
2.3.6. In vitro scaffold degradation 
The physiological stability and degradability of the scaffolds were evaluated by 
measuring the degradation rate as well as the ion release to the media. Briefly, three 
scaffolds (30 mg) per group and time point were immersed in 10 mL of PBS solution 
(pH 7.4) at 37 °C over the course of 4 weeks. At scheduled time points (7, 14, 21 and 28 
days), scaffolds were removed from the liquid, rinsed with Milli-Q water and dried into 
oven at 40 °C overnight. The percentage of the weight loss was calculated as follows:  𝑊𝑒𝑖𝑔ℎ𝑡 𝐿𝑜𝑠𝑠 % = 100 ∙ 𝑊! −𝑊! 𝑊!                                      (7) 
where Wi is the starting dry weight and Wt is the dry weight at time t.    
At each time point, PBS was collected and refresh with new one. The media samples 
were filtered, treated with nitric acid and diluted in Milli-Q water for evaluation of 
element concentration (Ca and Mg) by ICP-OES. 
2.3.7. Enzymatic degradation 
Crosslinked scaffolds (RCP, Ap/RCP and MgAP/RCP) were weighted (~5mg), 
immersed in 1 mL of 0.1 M Tris-HCl (pH 7.4) containing 25 CDU/mL of collagenase 
(Collagenase from Clostridium histolyticum, ≥125 CDU/mg solid, Sigma Aldrich) and 5 
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mM CaCl2 and incubated for 24 hours at 37 °C. After 24 hours, the reaction was 
stopped. The extent of scaffold degradation was determined by measuring the weight 
loss of the scaffolds (previously described) and the protein release to the supernatant 
was quantified by a colorimetric assay (Kit DC Protein Assay, Bio-Rad). Three 
scaffolds per condition were analysed.  
2.4. In vitro test  
2.4.1. Cell viability and proliferation 
Cell viability was qualitatively assessed with live/dead assay kit (Invitrogen) according 
to manufacturer's instructions. This assay is based on the simultaneous determination of 
live and dead cells with two probes, Calcein acetoxymethyl (Calcein AM) and Ethidium 
homodimer-1 (EthD-1), measuring recognized parameters of cell viability, intracellular 
esterase activity and plasma membrane integrity respectively. One sample per group 
was analysed. 
Cell viability and proliferation were also quantitatively assessed using MTT assay. 
Briefly, cell/scaffold constructs were incubated with 150 µL of MTT solution (3-(4,5-
dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide) for 2 h at 37 °C. In this assay, 
the metabolically active cells react with the tetrazolium salt in the MTT reagent to 
produce a formazan dye. Then, scaffolds were transferred to a tube containing 1 mL of 
dimethyl sulfoxide (DMSO) that dissolved formazan crystals. 200 µl of supernatant was 
transferred to 96-well plate and the absorbance was read at 570 nm using a Multiskan 
FC Microplate Photometer (Thermo Scientific). Three samples per group were analysed 
at each time point. This absorbance is directly proportional to the number of 
metabolically active cells.  
2.4.2. Cell morphology 
Cell adhesion and morphology was assessed by SEM observations. The samples were 
washed with 0.1 M sodium cacodylate buffer, fixed in 2.5% glutaraldehyde in 0.1 M 
sodium cacodylate buffer for 2 h at 4 ºC, washed again in 0.1 M sodium cacodylate 
buffer and then freeze-dried. Samples were fixed on aluminium stubs using a carbon 
tape, sputtered with a 20 nm thick gold layer and analysed using SEM (ESEM FEI 
Quanta 200).  
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2.4.3. Cell migration 
Two samples per condition were collected and fixed in 4% (w/v) paraformaldehyde 
(PFA). After cell permeabilization with 0.1 % (v/v) Triton X-100, samples were 
incubated with DAPI 300 nM (Invitrogen) for 7 min and washed with PBS. Scaffolds 
were cut longitudinally and cell migration from top to the bottom of the scaffold was 
analysed with an Inverted Ti-E fluorescence microscope (Nikon). The number of cells 
in the upper surface (external part) and in three different inner areas (top, middle and 
bottom) was quantified with ImageJ software for each scaffold composition.  
2.4.4. Quantitative real-time polymerase chain reaction (qPCR)  
The gene expression profile of mesenchymal stem cells (MSCs) cultured on the three 
different scaffold compositions was assessed using a real time-quantitative polymerase 
chain reaction (qPCR). The RCP scaffold was used as a calibrator in order to obtain a 
relative quantification. After scheduled times of cell culture, total RNA was harvested 
using Tri Reagent, followed by the Direct-zol RNA MiniPrep kit (Zymo Research) 
according to manufacturer's instructions. RNA integrity was analysed by native agarose 
gel electrophoresis and its quantification was performed by the Qubit® 2.0 Fluorimeter 
together with the Qubit® RNA BR assay kit, following manufacturer's instructions 
(Invitrogen). Total RNA (500 ng) was reverse transcribed to cDNA using the High-
Capacity cDNA Reverse Transcription Kit, according to manufacturer's instructions 
(Applied Biosystems). Relative quantification of the gene expression was performed by 
StepOneTM Real-Time PCR System (Applied Biosystems). The genes under studied 
were: alkaline phosphatase (ALP), collagen I (ColI), osteopontin (OPN), osterix (OSX), 
runt-related transcription factor 2 (RUNX2), bone sialoprotein (BSP), secreted protein 
acidic and rich in cysteine (SPARC) known as osteonectin, bone gamma-
carboxyglutamic acid-containing protein (BGLAP) known as osteocalcin, vascular 
endothelial growth factor (VEGF), transforming growth factor (TGF-β), bone 
morphogenetic protein (BMP-2) and glyceraldehydes-3-phosphate dehydrogenase 
(GAPDH), used as housekeeping gene,  
Data were collected using the OneStep Software (v.2.2.2) and relative quantification 
was performed using the comparative threshold (CT) method (ΔΔCT) where relative 
gene expression level equals 2-ΔΔCt. Three scaffolds per group were analysed in three 
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technical replicates; error bars reflect one standard error of the mean of 3 technical 
replicates as described elsewhere.4,5 
2.4.5. Western Blot Analysis 
After 14 and 28 days the cells were lysed in a Radioimmunoprecipitation buffer (RIPA 
buffer) supplemented with a proteinase inhibitor cocktail (Cell Signaling). Protein 
concentration in each cell lysate supernatant was determined by a colorimetric assay 
(Kit DC Protein Assay, Bio-Rad). The protein samples were diluted in sample buffer 
(3:1), and loaded and separated in a 4–20% Mini-PROTEAN TGX stain-free protein 
gels (BioRad), using a Mini-PROTEAN electrophoresis cell kit (Bio-Rad). 
The proteins were then transferred to nitrocellulose membranes by means of a Trans-
Blot Turbo™ transfer system (BioRad), with the blots incubated thereafter for 30 min at 
room temperature in a blocking solution of 5% non-fat dry milk in PBS. The 
membranes were incubated overnight at 4 °C with primary rabbit antibody anti-β-
catenin (Abcam) and anti-β-actin (Cell Signaling) as internal control, and then 
incubated with a horseradish goat peroxidase-linked secondary antibody anti-rabbit 
(Bio-Rad) for 30 min. An enhanced chemiluminescence kit (ECL, BioRad) was used to 
visualize the protein bands with ChemiDoc XRS+ (Bio-Rad). In order to evaluate the 
relative protein expression, the β-catenin band intensities were quantified by 
densitometry using ImageLab Software and were then normalized over the signal of the 
corresponding bands of β-actin (loading control). 
2.4.6. Immunofluorescence 
Osteogenic related markers were also analysed by immunofluorescence through the 
staining of runt-related transcription factor 2 (RUNX2). After 14 days of cell culture, 
cells seeded on the samples were fixed in 4% (w/v) PFA. Blocking was performed with 
bovine serum albumin (1% BSA) and 10 % normal goat serum (NGS). Then, cells were 
permeabilized with 0.1% Tryton X-100 for 20 min with slow agitation. Samples were 
incubated overnight at 4 °C, with antibodies anti-RUNX2 (Abcam). Primary antibodies 
were probed with the secondary antibodies Cy3 sheep anti-mouse (Molecular Probes), 
for 45 min at room temperature. Cell nuclei were stained with DAPI 300 nM for 10 
min. Images of one sample per group were acquired by an Inverted Ti-E fluorescence 
microscope (Nikon). 
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2.5. Statistical analysis 
Results are expressed as the mean ± standard error of the mean (SEM). Data analysis 
was made by two-way analysis of variance (ANOVA), followed by Bonferroni’s post 
hoc test. Statistical analyses were performed by the GraphPad Prism software (version 
6.0), with statistical significance set at p<0.05. 
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Chapter 3: Understanding biomineralization of recombinant 
collagen peptide in the presence of magnesium 
 
3.1. Introduction 
Biomineralization is the process by which living organisms create composite materials 
of amazing complexity for a variety of purposes, including mechanical support, 
navigation, and protection against predation.1 The study of biomineralization process 
has attracted the attention of scientists as a source of inspiration to achieve advanced 
materials with complex shape, hierarchical organization and well-defined size, 
morphology and structure. 
Bone is a highly complex mineralized tissue whose building blocks are made of a 
collagen matrix reinforced by the intra- and interfibrillar mineralization of apatite (Ap) 
nanocrystals.2 The biomineralization process through which organic macromolecules 
control the formation mechanisms and the crystallization pathways of Ap is still far 
from being fully comprehended. In the last years, it was unequivocally demonstrated 
that Ap formation in biological tissue does not occur directly by the association of ions 
from solution according to the classical nucleation theory, but proceeds through a “non-
classical” crystallization pathway via an amorphous calcium phosphate (ACP, 
Ca3(PO4)2·H2O) precursor phase.3-5 It has been suggested that non-collagenous proteins 
(NCPs) act as a process-directing agent in bone mineralization.2 Many of NCPs (i.e., 
osteonectin and various phosphoproteins such as osteopontin, osteocalcin, 
phosphophoryn and bone sialoprotein) are rich in carboxylate groups coming from 
aspartic and glutamic acid residues which can bind calcium ions present in solutions 
controlling the Ap crystallization mechanism.2 Inspired by this biologically controlled 
mineral formation, syntheses of bone-like Ap have been carried out in the presence of 
several amino acids,6-8 biological macromolecules such as carboxylate-rich proteins9 
and small organic molecules containing carboxylate groups such as citrate.10-12 
Concretely, citrate has been proposed to play a dual role in controlling apatite formation 
mechanism: driving a growth pathway via an amorphous precursor10,11 and controlling 
the size of nanocrystals by the non-classical oriented aggregation mechanism.12 
Furthermore, in vitro collagen mineralization in presence of polyaspartic acid (pAsp) 
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has shown that pAsp inhibits Ap nucleation in soluble form while promotes nucleation 
when attached to a substrate as collagen fibres.2,13 
Bio-inspired natural collagen mineralization approaches mimicking in vivo 
biomineralization have been explored for the development of advanced materials for 
bone regeneration,14 exhibiting complex shape, hierarchical organization and controlled 
size, under body-like conditions in aqueous environments. The process enabled the 
activation of the various control mechanisms that drive the assembling, 3D organization 
and mineralization of collagen fibrils thus generating hybrid fibrous scaffolds with high 
mimicry of the compositional and morphological features of those of newly formed 
bone tissue.15,16 Nevertheless, the use of natural collagen derived from animal tissues 
may present some limitations such as: the quality and the purity that influence collagen 
performance, the possibility of immunological reactions in susceptible patients due to 
their non-human protein composition or even the possible contamination with 
pathogenic substances.17 Therefore, many approaches such as mammalian and insect 
cells or biotechnological yeast process have been engineered to express high level of 
recombinant collagen type I derived proteins with high reproducible quality, leading to 
a reliable performance. Several authors have studied the biomimetic mineralization of 
recombinant human like collagen as potential biomaterial for bone regeneration.18-20 
Previous works have carried out the mineralization of recombinant collagen by adding a 
CaCl2 solution to previously prepared collagen solution and mixing them for a period of 
20 min. Then, NaHPO4 solution was added slowly. The pH was regulated with NaOH 
solution at the end of the process.18,19 Wang et al. carried out mineralization of 
recombinant collagen by a similar protocol.20  
Herein, we proposed the bioinspired mineralization of recombinant collagen type I 
derived peptide (RCP) containing tri-amino acid sequence arginine-glycine-aspartic 
acid (RGD) that is the cell attachment site of a large number of adhesive extracellular 
matrix, blood and cell surface proteins. In fact, nearly half of the over 20 known 
integrins recognize this sequence in their adhesion protein ligands.21 The mineralization 
process has been adapted from the protocol developed by A. Tampieri et al.22 in order to 
synthesize biohybrid composite material with similar properties to biological bone using 
as source material animal-based collagen fibres. Magnesium (Mg) ions were introduced 
during the biomineralization process to closer mimic bone Ap ionic composition (Mg ≈ 
0.5-1 wt.%).23 The role of both RCP and Mg ions in controlling the precipitation of the 
mineral phase was in depth evaluated. 
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3.2. Methods 
The synthesis of Ap nanocrystals was carried out by the neutralization reaction in 
aqueous environment through dropping 5 mL of H3PO4 aqueous solution (0.71 M) into 
5 mL of a basic aqueous suspension of Ca(OH)2 (1.18M) (Ca/P molar ratio of 1.67). 
Mg-doped Ap (MgAp) as well as Ap synthesized in the presence of RCP (RCPAp) and 
both RCP and Mg (RCPMgAp) were prepared in the same conditions of Ap with 
slightly modifications. Namely MgAp was obtained by adding MgCl2·6H2O (at 
different Mg/Ca molar ratios, Table 1) to Ca(OH)2 suspension whereas RCPAp was 
synthesized by dissolving RCP (1.5 mM) into H3PO4 aqueous solution at 40 °C (Figure 
1). RCPMgAp was synthesized by dissolving RCP (1.5 mM) into H3PO4 aqueous 
solution at 40 °C and dropping this acid solution to Ca(OH)2 suspension containing 
MgCl2·6H2O (at different initial Mg/Ca molar ratios, Table 1). 
After neutralization reaction, the mixture was kept under stirring for 2 hours at room 
temperature. Then, mineralized suspension was washed three times by centrifugation 
and freeze-dried at −40 °C under vacuum (0.0858 mbar) overnight.  
Table 1. Molar concentrations of reactants used for mineralization of Ap nanocrystals 
in the presence of Mg and/or RCP. 
Sample Ca(OH)2. M 
H3PO4, 
M 
MgCl2·6H2O, 
M 
RCP , 
mM 
Ap 1.18 0.71 ---- ---- 
MgAp5 1.18 0.71 0.06 ---- 
MgAp10 1.18 0.71 0.12 ---- 
MgAp15 1.18 0.71 0.18 ---- 
RCPAp 1.18 0.71 ---- 1.5 
RCPMgAp5 1.18 0.71 0.06 1.5 
RCPMgAp10 1.18 0.71 0.12 1.5 
RCPMgAp15 1.18 0.71 0.18 1.5 
 
3.3. Results  
The mineralization was carried out by neutralization reaction as we described 
previously.24 We monitored the variation of the conductivity (k) of the reaction mixture 
with the time as an in situ measure of precipitation and phase evolution of calcium 
phosphate compounds during the mineralization process (Figure 1). Since the phase 
transformation leads to a change in composition in both the solution and the precipitate, 
in situ measurements on the variation of ionic concentration in solution during the 
reaction may give an insight into the reaction mechanism. Three regions can be 
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identified in the conductivity graph according to the rate of variation of conductivity 
(dC/dt) respect to the time (the inset graph Figure 1): i) conductivity decreased slowly 
(dC/dt≈-0.1); ii) conductivity decreased abruptly with a rate of -1 mS/cm per min and 
iii) the conductivity remained stable (dC/dt≈0). 
 
 
 
 
 
 
 
  
Figure 1. Sketch of RCP mineralization protocol. The graph displays the variation of 
the conductivity of the reaction mixture versus the reaction time. Inset displays the rate 
of variation of conductivity (dC/dt) respect to the time. 
 
Figure 2a displays the XRD patterns of apatites synthesized with different Mg/Ca ratio 
in the absence (Ap, MgAp5, MgAp10 and MgAp15) and in the presence of RCP 
(RCPAp, RCPMgAp5, RCPMgAp10 and RCPMgAp15). All XRD patterns exhibit 
reflections ascribed to HA (ASTM card file No 9-432). Irrespectively of the 
mineralization conditions, the peaks are rather broad indicating low crystallinity and 
nano-sized dimensions of the diffracting crystal domains. The XRD patterns of the 
samples precipitated in the presence of the highest Mg concentrations (MgAp15 and 
RCPMgAp15) display the reflection at 29.40° (2θ) corresponding to the (104) plane of 
calcite (ASTM card file No. 5-586). The presence of a small quantity of calcite could be 
due to the spontaneous diffusion of atmospheric CO2 during neutralization reaction or to 
the presence of CaCO3 impurities in the reactants. CO32- ions may affect calcium 
phosphate precipitation by blocking phosphate (resulting in a B-type carbonate 
substitution) or hydroxyl nucleation sites (resulting in a A-type carbonate substitution) 
or inducing CaCO3 precipitation.25 The average size of crystal domains along c-axis 
(D[002]) and a-b plane (orthogonal to the c-axis, D[310]), roughly estimated by using the 
Scherrer’s equation, are reported in Table 2. Apatites synthesized in the presence of Mg 
exhibit a considerable reduction of the crystallite size along the c-axis providing more 
isometric crystals, in comparison to that of the samples synthesized without Mg (Ap and 
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RCPAp). This effect could be attributed to the inhibitory role of Mg on Ap crystal 
growth.26 Individual effect of RCP on Ap crystallization also causes a decrease on 
crystal size along the c-axis but less prominent than in the case of the synergistic effect 
with Mg (Table 2). Moreover, the diffraction peaks of samples synthesized in the 
presence of magnesium (MgAp5, MgAp10 and MgAp15) are slightly shifted to higher 
2θ values (Table 2) likely revealing a decrease in lattice parameters. This reduction 
could be associated to the partial Ca2+ (ionic radius: 0.99 Ǻ) substitution by Mg2+ ions 
(ionic radius: 0.72 Ǻ), as previously reported.27 
 
 
 
 
 
 
 
 
 
Figure 2. XRD (a) and FTIR (b) spectra of synthesized samples: i) Ap; ii) MgAp5; iii) 
MgAp10; iv) MgAp15; v) RCPAp; vi) RCPMgAp5; vii) RCPMgAp10 and viii) 
RCPMgAp15. 
 
FTIR spectrum (Figure 2b) of synthesized samples exhibits phosphate vibrational peaks 
corresponding to HA: the main band of phosphate group appears at ~1032 cm-1 with 
shoulders at 1046 cm-1 and 1087 cm-1 due to the triply degenerated asymmetric 
stretching mode (ν3PO4) and less intense peaks associated to triply degenerated bending 
mode (ν4 of the O-P-O bond) appear at 602, 574 (shoulder) and 561 cm-1.28 FTIR 
spectrum of RCPMgAp15 exhibits broad and relatively featureless phosphate bands 
characteristic of ACP.29 Sample crystallinity is calculated by evaluating the extent of 
splitting of the ν4 absorption peak at 560-600 cm-1 (Table 2).30 Splitting factor (SF) 
values decreased for increasing concentrations of Mg in the absence and in the presence 
of RCP ranging from 2.40 up to 3.76, which are in the range of SF values determined 
for young and mature zebrafish bone.3 SF of RCPMgAp15 spectrum was no possible to 
calculate due to the broadening and overlap of the peaks under study. FTIR spectra 
show the ν2 vibration mode of CO32- group at 873 cm-1 and ν3 vibration mode of CO3 at 
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1424, 1454 and 1484 cm-1, both of them corresponding with B-type carbonation 
(substitution of PO4 by CO3).31  
 
Table 2. Position of (002) peak and average crystalline domain size along the [002] and 
[310] directions estimated through Scherrer’s approximation for apatite nanocrystals 
synthesized under different conditions. (b) SF, crystallinity index (splitting factor) 
evaluated from v4 PO4 vibrational mode in FTIR spectra.30  
Sample (002) position (2θ°)  D[002], nm D[310], nm 
D[002]/ 
D[310]  
SFb 
Ap 25,877 60 10 6 3.76 
MgAp5 25,890 34 8 4 2.78 
MgAp10 25,900 31 7 4 2.68 
MgAp15 25,908 34 9 4 2.49 
RCPAp 25,874 51 9 6 3.51 
RCPMgAp5 25,881 38 10 4 2.83 
RCPMgAp10 25,879 34 9 4 2.40 
RCPMgAp15 25,876 38 9 4 --- 
 
Samples were characterized by Raman Spectroscopy as a complementary technique. 
Raman spectra (Figure 3a) display the typical phosphate peaks belonging to HA. 
Concretely, the most intense peak at 961 cm-1 corresponds to the symmetric stretching 
mode (ν1) of the tetrahedral PO4 group while other less intense peaks appear at 433 cm-1 
with a shoulder at 450 cm-1 (double degenerated bending mode ν2), at 589 cm-1 with a 
shoulder at 612 cm-1 (triply degenerated bending mode ν4) and at 1051, 1075 and 1087 
cm-1 (triply degenerated asymmetric stretching mode ν3).28 The main peak at 961 cm-1 is 
slightly broader in the spectra of apatites synthesized in the presence of Mg and RCP, 
showing a more prominent widening for the combined effect of RCP and Mg/Ca molar 
ratio of 0.15 (RCPMgAp15) (Figure 3b). The fitting of this peak for four representative 
samples (Ap, MgAp15, RCPAp and RCPMgAp15) (Figure 3c) shows the existence of 
two overlapping features: one at 952 cm-1 attributed to ACP32-34 and other one at 961 
cm-1 attributed to HA.10 The area ratio of both features (A952/A961) was quantified for all 
samples. The results indicated a higher amount of ACP when mineralization was carried 
out at the highest Mg/Ca molar ratio (MgAp15) or in the presence of RCP (RCPAp) 
(Figure 3d). This effect was more prominent for the samples synthesized in presence of 
RCP and the highest Mg/Ca molar ratio (RCPMgAp15, Figure 3d). In addition, 
RCPMgAp5, RCPMgAp10 and RCPMgAp15 spectra also show a decreasing intensity 
and a widening of the apatitic νOH mode at ~3570 cm-1 (inset of Figure 3a), confirming 
the presence of higher amount of ACP.  
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Figure 3. Raman spectra from 400-1150 cm-1 (a) and in the ν1 PO4 mode region (b) 
collected for synthesized samples: i) Ap; ii) MgAp5; iii) MgAp10: iv) MgAp15; v) 
RCPAp; vi) RCPMgAp5; vii) RCPMgAp10 and viii) RCPMgAp15. (c) Curve fittings 
of the peak at ca 961 cm-1 related to symmetric stretching mode (ν1) of the tetrahedral 
PO4 group in Raman spectra for 4 representative samples Ap (i), MgAp15 (iv), RCPAp 
(v) and RCPMgAp15 (viii). The vertical graph bar (d) represents the area ratio of ν1 
peaks from ACP (952 cm-1) and Ap (961 cm-1) for all the samples. Data are expressed 
as mean ± SD (n=3). 
 
A deeply characterization by TEM, ICP-OES and TGA has been carried out for 
synthesized samples in the presence of the highest Mg/Ca molar ratio and/or RCP (Ap, 
MgAp15, RCPAp, RCPMgAp15). TEM observations of Ap, MgAp15, RCPAp and 
RCPMgAp15 revealed that poor crystalline Ap nanoparticles were obtained in all 
conditions without relevant differences in terms of nanoparticle dimensions and shape 
among them (lendth≈100nm and width≈10nm) (Figure 4). SAED pattern (inset in 
Figure 4a) of Ap elongated nanocrystals showed diffraction rings of the typical 002 and 
211 hydroxyapatite reflections (HA, ASTM card file 09-432). We can distinguish the 
presence of smaller round shape nanoparticles (indicated by the white arrows) that 
could be attributed to ACP, according to Raman spectroscopy studies. Inspections at 
higher magnifications of RCPMgAp15 (inset Figure 4d) revealed lattice fringes spaced 
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at ca. 0.344 nm corresponding to the distance of the (002) plane of HA (ASTM card file 
09-432). Moreover, the edge of the nanocrystals exhibits lack of order that could be 
associated to the presence of an amorphous layer covering the crystalline core, as 
previously proposed.10,35  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. TEM micrographs of powdered samples synthesized in different conditions: 
(a) Ap, where inset shows corresponding SAED pattern; (b) MgAp15; (c) RCPAp and 
(d) RCPMgAp15, where inset shows High-Resolution TEM images of a nanocrystal.  
 
The chemical composition of Ap, MgAp15, RCPAp and RCPMgAp15 was analyzed by 
ICP-OES and TGA (Table 3). ICP-OES analysis indicated that the Mg content in the 
precipitates was lower than that used during the synthesis (Mg/Ca=15 % mol). Less 
than a half of the initial amount of Mg was incorporated into MgAp15 precipitates 
whereas higher Mg content was incorporated in RCPMgAp15 samples (Table 3). The 
Ca/P ratio of Ap and RCPAp samples were closer to stoichiometric HA (Ca/P=1.67) 
whereas MgAp15 and RCPMgAp15 showed lower values. The specific surface area 
(SSA) of the precipitates is also shown in Table 3. Noticeably, samples synthetized in 
the presence of Mg and/or RCP exhibited higher SSA than Ap. 
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Table 3. Chemical composition of Ap, MgAp15, RCPAp and RCPMgAp15 samples. 
(a) Elemental composition calculated from ICP-OES analysis; (b) RCP and water 
content (wt.%) determined from TGA curves and (c) specific surface area calculated 
from BET adsorption. Data are expressed as mean ± SD (n=3). 
Sample Ca/P 
(mol)a 
Mg 
(wt.%)a 
Mg/Ca 
(%mol)a 
RCP 
(wt%)b 
Water 
(wt.%)b 
SSABET 
(m2g-1)c 
Ap 1.58±0.10 ------ ------ ----- 4.86±0.17 73.36 
MgAp15 1.54±0.04 1.06±0.02 5.14±0.14 ------ 6.28±0.11 99.21 
RCPAp 1.64±0.06 ----- ------ 2.87±0.32 6.63±0.24 95.77 
RCPMgAp15 1.54±0.03 1.50±0.01 8.05±0.12 3.79±0.44 9.24±0.19 91.14 
 
Thermogravimetric analyses were carried out to quantify the presence of RCP (water 
soluble peptide) that remained attached to Ap after the washing procedure (Figure 5). 
Firstly, thermogravimetric analysis of RCP stock material was carried out to determine 
its degradation temperature that was closed to 273 °C (TGA-DSC curve, Figure 5a). 
RCP was completely degraded at 700 °C. TGA curve of Ap, MgAp15, RCPAp and 
RCPMgAp15 (Figure 5b) mainly exhibited four weight losses that were attributed to 
adsorbed water (from room temperature to 150 °C), structural water (from 150 to 400 
°C),36 RCP (from 270 to 700 °C) and carbonate (from 700 to 1000 °C).10 Table 3 covers 
the weight loss belongs to decomposition of water and RCP calculated from TGA 
curves of synthesized samples. Higher amount of RCP was bound to Ap when 
mineralization took place in presence of magnesium (RCPMgAp15). Moreover, higher 
water content was obtained for the samples synthesized in the presence of Mg and/or 
RCP when compared to Ap. Probably, a higher amount of ACP in the Mg- and/or RCP-
containing sample is the responsible of this finding.  
 
 
 
 
 
 
 
 
 
Figure 5. (a) TGA/DSC curve of RCP where the thermal degradation temperature of 
RCP was determined close to 273 °C and (b) TGA curves of Ap, MgAp15, RCPAp and 
RCPMgAp15 samples.  
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3.4. Discussion 
In this chapter, we have adapted the bioinspired mineralization protocol of natural 
collagen developed by Tampieri et al.37 for the mineralization of recombinant collagen 
peptide. We have studied the process in situ with conductivity measurements and 
characterized the powdered samples to evaluate the role of RCP and/or Mg in the 
mineralization mechanism of calcium phosphate.  
The in situ measurement of the electrical conductivity variation, that can be considered 
to be an indirect way of measuring ionic concentration, might give an insight into the 
reaction mechanism and transformations. Electrical conductivity values during 
mineralization indicated the presence of three regions. According to previous studies,38 
region I can be associated to ACP formation step and region II to ACP to HA 
transformation. No noticeable changes on the conductivity in the region III might 
indicate that the final product was reached exactly after the end of acid addition. Several 
calcium phosphate phases have been proposed as Ap precursor phase depending on pH 
of the solution. In slightly acidic solutions the transformation occurs via octacalcium 
phosphate (OCP, Ca4H(PO4)3·2.5H2O) and/or dicalcium phosphate dihydrate (DCPD, 
CaHPO4·2H2O) whereas in basic solutions, it occurs via amorphous calcium phosphate 
(ACP, Ca3(PO4)2·H2O).39-41 Prakash et al. correlated the variations of the conductivity 
of the reaction mixture with ionic concentration and determined that Ca3(PO4)2 is the 
precursor phase of HA during the CaP precipitation through dropwise phosphoric acid 
into calcium hydroxide solution.38  
In our work, poor crystalline apatites (Ap) were obtained in all the conditions, as 
indicated XRD and FTIR spectra of synthesized samples. Furthermore, the presence of 
ACP was detected by Raman Spectroscopy. In detail, crystal domain sizes estimated 
along [002] and [310] directions have put in evidence the role of Mg in inhibiting Ap 
crystal growth along the c-axis, providing thus more isometric crystals. FTIR indicated 
lower splitting factor for crystallization experiments in the presence of Mg and/or RCP. 
It was not possible to calculate the SF for RCPMgAp15 due to lack of crystallinity. SF 
values were in the range of that found for fin bones of zebrafish. Lower SF values are 
related to young forming bones whereas higher values correspond to mature bone, 
indicating the increase of crystallinity with the bone maturation.3 Raman spectra have 
also shown that Mg and RCP synergistically induced a stronger stabilization of ACP 
with respect to their individual role. In fact, RCPMgAp15 seems to be mainly 
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composed for ACP. It has been previously proposed that Mg kinetically hinders 
nucleation and subsequent growth of Ap by competing for structural sites with 
chemically similar but larger Ca ions, favouring stabilization of ACP.26 Francesco 
Abbona et al. determined that the presence of magnesium in the solution prolonged by 
at least four times the induction time of transformation of ACP into HA. The influence 
of magnesium was attributed to its incorporation in the ACP cluster and Ap pre-nuclei 
and also its adsorption onto the surfaces of ACP and Ap crystallites.42 The inhibitory 
effect of organic molecules (i.e., amino acids, biological macromolecules or small 
molecules such as citrate) on Ap crystallization via ACP precursors is also well 
reported.6,7,9,10,43 In fact, NCPs, due to their poly-anionic character, have been proposed 
to play an essential role in controlling mineral deposition and growth during bone 
formation.2,44,45 Conversely, only few studies on the simultaneous action of Mg and 
organic molecules as stabilizers of ACP have been carried out to date. In particular, Tao 
et al. pointed out that either Mg or aspartate monomer can stabilize the ACP phase 
whereas their cooperative effect consists in a switch on crystallization mechanism in 
which Mg inhibits ACP to Ap transformation whilst aspartate monomers promote the 
transformation.46 On the other hand, Yang et al. suggested that acidic (Asp), neutral 
(Gly) and basic (Lys) amino acids in the absence and in the presence of Mg ions 
promoted Ap nucleation by shortening the induction and transformation times.7 Despite 
that the amino acid sequences for a number of proteins involved in the 
biomineralization processes have been determined, the effect of specific amino acid 
sequences and Mg ions is still unclear. 
Considering that relevance differences were found between Ap, MgAp15, RCPAp and 
RCPMgAp15 samples, these samples were thoroughly investigated and Mg/Ca molar 
ratio 0.15 was selected for the further studies along this thesis. 
TEM images revealed that Ap nanocrystals surrounded by an amorphous layer were 
obtained for all evaluated conditions. In fact, the presence of round shape nanoparticles 
in TEM images of MgAp15 and RCPMgAp15 might indicate the role of ACP as 
metastable precursor phase. Elemental compositional analysis by ICP-OES indicated a 
higher Mg incorporation on synthesized Ap in the presence of RCP (RCPMgAp15) 
compared to synthesized samples with the same Mg/Ca molar ratio but in the absence of 
RCP (MgAp15). Ca/P ratio of RCPMgAp15 samples was lower than that of 
stoichiometric HA (Ca/P=1.67) that can be associated to the presence of ACP that 
present lower Ca/P molar ratio.47 RCPMgAp15 showed higher Mg content compared to 
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MgAp15. This effect could be attributed to a larger presence of amorphous phase for 
RCPMgAp15 as well as ion-sequestration by positively charged carboxylate groups 
from aspartic and glutamic acid residues of RCP which remained adsorbed into Ap 
surface of RCPMgAp15, as indicated TGA analysis. TGA curve of RCPMgAp15 
showed higher water content as well as a higher amount of bound RCP respect to 
RCPAp samples. These effects can be associated to the fact that Mg sites can coordinate 
and bind water in a higher extent than Ca, thus leading to a more effective protein 
adsorption.48 
3.5. Conclusions 
Understanding the mineralization mechanism of synthetic peptide has recently aroused 
great interest especially in the development of advanced materials for bone 
regeneration. Herein, we study the mineralization of a recombinant collagen type I 
derived peptide (RCP) enriched with RGD sequences through a neutralization reaction, 
previously applied for natural collagen mineralization. Moreover, magnesium ions (Mg) 
are introduced to closer mimic bone composition. The role of both RCP and Mg ions in 
controlling the precipitation of the mineral phase is in depth evaluated. TEM and X-Ray 
powder diffraction reveal the crystallization of nanocrystalline apatite (Ap) in all the 
evaluated conditions with a clear effect of Mg on decreasing crystallite size along c-
axis. However, Raman spectra point out also the precipitation of amorphous calcium 
phosphate (ACP). This amorphous phase is more evident when RCP and Mg (Mg/Ca 
molar ratio 0.15) are at work, indicating the synergistic role of both in stabilizing the 
amorphous precursor. To the best of our knowledge this work represents the first 
attempt to mineralize recombinant collagen type I derived peptide proving the 
simultaneous effect of the organic phase (RCP) and Mg on ACP stabilization. This 
study opens the possibility to engineer, through biomineralization process, advanced 
hybrid matrices for bone regeneration (Chapter 4). 
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Chapter 4: Biomimetic mineralization of recombinant 
collagen peptide to obtain hybrid matrices for bone 
regeneration 
4.1. Introduction 
Bone, in dry conditions, is defined as bioceramic composite mainly made of collagen 
type I (~30 wt.%) and hard inorganic components (~70 wt.%, belonging to poor 
crystalline hydroxyapatite, HA).1 The degree of mineralization varies within different 
bone tissues. For instance, mineral density of trabecular bone from the calcaneus was 
measured at 1.136±0.147 g/cm3, while in trabecular bone from the iliac crest it was 
indicated close to 1.099±0.077 g/cm3.2 Composite biomaterial can combine the 
advantages of both materials, the strength of a ceramic phase (i.e., calcium phosphate 
phase, CaP) and the toughness and plasticity of a polymer phase. Furthermore, the 
introduction of CaP into an organic matrix could enhance the biological tissue response 
owing to the osteoconductive properties of CaP such as hydroxyapatite.3,4 However, the 
blending of ceramic materials with polymers presents several drawbacks, including poor 
dispersion and agglomeration that leads to heterogeneous composition of the blend as 
well as reduction in mechanical properties.4 Substantial research efforts have already 
been focused on the development of ceramic-polymer composites for bone graft 
applications, in which the major challenge was related to achieve a good chemical 
and/or physical bond between the polymer and the ceramic phase. For instance, bio-
inspired mineralization of natural collagen (e.g., extracted from horse tendon) has been 
extensively applied for the development of nanocomposite scaffolds with good 
interaction between the mineral and the organic phase.5 The process enables the direct 
nucleation of HA nanocrystals on self-assembled collagen fibres. In this case, the two 
components (80 wt.% HA and 20 wt.% collagen) exhibited strong interactions since 
collagen negatively charged carboxylate groups bound to the calcium ions of HA. The 
composite materials showed a complete analogy with calcified natural tissue.6  
The goal of this PhD is the fabrication of new hybrid scaffolds with enhancing 
biofunctionality through biomimetic mineralization (adapted from bioinspired 
mineralization of natural collagen developed by Tampieri et al.6) of a recombinant 
collagen type I derived peptide (RCP) enriched in RGD sequences. However, unlike 
collagen, RCP is water-soluble and does not self-assembly into large microfibers. 
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Therefore, the forthcoming goal is to determine the maximum mineral extent, obtained 
after RCP mineralization, to maintain a good chemical interaction between the two 
phases and a uniform mineral integration into the organic matrix since both of them will 
ensure a homogeneous composition of the designed scaffolds through freeze-drying the 
mineralized slurry. 
In addition to the chemical similarity to the bone tissue, the nanocomposite biomaterials 
obtained through biomimetic mineralization also exhibit unique surface properties such 
as surface topography, specific surface area, surface wettability and surface energy. It is 
well-known that material surface properties mediate specific protein adsorption (i.e., 
fibronectin, vitronectin and laminin) and bioactivity before cells adhere on implants, 
further regulating cell behaviour and dictating tissue regeneration and osseointegration 
of the material.7 Several studies have demonstrated that nanostructured materials with 
cell favourable surface properties may promote greater amounts of specific protein 
interactions to more efficiently stimulate new bone growth compared to conventional 
materials.8 Biomimetic mineralization approach allows to tailor the physic-chemical 
properties of the mineral phase and subsequent interfacial properties of designed 
materials enhancing their osteoconductivity and osteoinductivity.9,10 For instance, 
previous in vivo studies of calcium phosphate coatings indicated that early bone 
formation was dependent on the nanosized hydroxyapatite features, but it was unclear 
whether this finding was an isolated effect of the chemistry, an isolated effect of the 
nanotopography or a combined effect of both.11 In this chapter, hybrid matrices are 
developed through biomimetic mineralization of RCP in the absence (Ap/RCP) and in 
the presence of magnesium (MgAp/RCP). The chemical interaction between mineral 
phase and organic matrix was evaluated by FTIR spectroscopy. Furthermore, mineral 
distribution in the organic matrix for both scaffold compositions was assessed by SEM 
and AFM. The interfacial properties were evaluated both at nanoscale (roughness 
values) and macroscopic level (hydrophobicity and water retention ability). The 
correlation between the scaffold interfacial properties and the extent of mineralization, 
the mineral composition, crystallinity and morphology and the mineral integration in 
organic matrix resulting from mineralization process of RCP was investigated. 
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4.2. Methods 
4.2.1. Prototype 3D scaffolds: Evaluation of the maximum mineral content 
3D scaffold prototypes with increasing mineral/organic weight ratio (min/org) were 
developed by biomimetic mineralization of RCP (previously described in chapter 3) and 
further freeze-drying of mineralized suspension. The reagent concentrations for each 
scaffold composition are summarized in table 1. The samples were characterized by X-
ray powder diffraction (XRD), thermogravimetric analysis (TGA) and scanning electron 
microscopy (SEM). 
Table 1. Concentrations of the reagents for the preparation of hybrid matrices with 
increasing min/org weight ratio. 
Min/Org 
(wt.%) 
Ca(OH)2. 
M 
H3PO4, 
M 
RCP , 
mM 
40/60 1.18 0.71 1.50 
50/50 1.58 0.95 1.56 
60/40 2.45 1.47 1.61 
70/30 4.03 2.42 1.70 
 
4.2.2. Preparation of hybrid matrices of different compositions 
Mineralized hybrid matrices (min/org=40/60) in the absence (Ap/RCP) and in the 
presence of magnesium (MgAp/RCP) were developed by the same mineralization 
protocol described previously for the synthesis of RCPAp and RCPMgAp15 samples, 
respectively (Chapter 3). In this case, mineralized slurry was freeze-dried after 2 hours 
of mineralization. Non-mineralized matrices (RCP) were also prepared as a control by 
freeze-drying RCP solution (7.5 wt.%). Samples were characterized by FTIR 
spectroscopy, SEM and atomic force microscopy (AFM). Wettability and swelling 
capacity of hybrid matrices were also evaluated.  
Scaffold prototypes and hybrid matrices were fabricated by freeze-drying in a teflon 
mould in the freeze-drier (5Pascal, Cinquepascal srl, Italy). The final freezing 
temperature was set up at −40 °C with a constant cooling rate of 10 °C/h. Once the 
samples reached -40 °C, drying process started by heating up to 25 °C with a heating 
rate of 5 °C/h under vacuum (0.0858 mbar). 
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4.3. Results 
4.3.1.  Amount of mineral suitable to obtain 3D structures 
Prototype 3D porous scaffolds were obtained for an initial min/org weight ratio up to 
60/40 whereas powdered and brittle samples were obtained for an initial min/org weight 
ratio of 70/30 (Table 2). XRD patterns of designed scaffolds showed the presence of 
hydroxyapatite (HA, ASTM Card file No 9-432,) as unique crystalline phase (Figure 
1a). The mineral content at the top and base of the scaffolds was calculated by TGA 
(Table 2) as the residual mass of the samples at 800 °C, temperature in which RCP is 
completely degraded (Td=273 °C, see chapter 3). The base of scaffolds showed a higher 
mineral content due to sedimentation of the mineral phase during the freezing stage 
(Table 2). In fact, scaffolds developed with higher initial min/org weight ratio, showed a 
higher mineral deposition with relevant difference on the mineral content from the top 
to the base of the scaffold (Figure 1b). Scaffolds with an initial min/org weight ratio of 
40/60 showed the most homogeneous mineral distribution.  
 
Table 2. Macroscopic structure of prototype scaffolds and mineral/organic weight ratio 
at the top and base of scaffolds calculated by TGA. 
(Min/Org)Th 
(wt.%) 
Structure 
(Min/Org)Top 
(wt.%) 
(Min/Org)Base 
(wt.%) 
40/60 Scaffold 40/60 45/55 
50/50 Scaffold 40/60 56/46 
60/40 Brittle Scaffold 46/54 63/37 
70/30 Powder ----- ----- 
 		
 
 
 
 
 
 
 
 
Figure 1. XRD (a) and TGA curves (b) of top (discontinuous line) and base (continuous 
line) of mineralized scaffolds developed with three different theoretical min/org weight 
ratio: 40/60, 50/50 and 60/40.  
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SEM observations showed a more homogeneous porous structure for prototype 
scaffolds with the lowest min/org weight ratio (40/60) whereas more compact and 
heterogeneous structures were obtained for scaffolds developed with higher initial 
mineral content (50 and 60 wt.%) (Figure 2). SEM images at higher magnification of 
the surface of the scaffolds (at the base of the scaffold) showed a uniform mineral 
incorporation into the organic matrix for scaffold prototypes developed with the lowest 
mineral content (40 wt.%). On the other hand, micrometric mineral aggregates 
(indicated with white arrows in Figure 2), that seemed not to be incorporated into the 
organic matrix, were identified at the base of scaffold prototypes with higher mineral 
content (50 and 60 wt.%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. SEM micrographs of the top and base of scaffold prototypes designed with 
increasing initial mineral/organic weight ratio: 40/60, 50/50 and 60/40. Scale bar: 250 
µm. Higher magnification SEM images of the scaffold surface at the base.  
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4.3.2.  How modification of mineralization protocol can alter macroscopic 
properties?  
The chemical interaction between the mineral and the organic phase of hybrid matrices 
was evaluated by FTIR spectroscopy. Figure 3 displays the FTIR spectrum of non-
mineralized matrix showing the RCP amide bands, i.e., amide I (1637 cm-1), amide II 
(1542 cm-1) and amide III (1242 cm-1).12 FTIR spectrum of Ap/RCP matrix exhibits 
amide bands of RCP together with phosphate vibrational peaks corresponding to HA: 
the main band of phosphate group appears at ~1032 cm-1 with shoulders at 1046 cm-1 
and 1087 cm-1 due to the triply degenerated asymmetric stretching mode (ν3PO4) and 
less intense peaks associated to triply degenerated bending mode (ν4 of the O-P-O bond) 
appear at 602, 574 (shoulder) and 561 cm-1.13 On the other hand, FTIR spectrum of 
MgAp/RCP matrix exhibits broad and relatively featureless phosphate bands 
characteristic of ACP.14 FTIR spectra of Ap/RCP and MgAp/RCP also show the ν2 
vibration mode of CO32- group at 873 cm-1 indicating the carbonation of the mineral 
phase.15 Moreover O-C-O stretching vibration of carboxylate groups from aspartic and 
glutamic acids containing in RCP sequence appears at 1392 cm-1 in the spectrum of 
RCP (Figure 3b). This peak is blue-shifted for mineralized matrices, appearing at 1398 
and 1408 cm-1 for Ap/RCP and MgAp/RCP, respectively. Shifts of the symmetric OCO 
stretching vibrations have been previously associated to the interaction of these 
functional groups with Ca and/or Mg ions.16,17  
 
 
 
	
	
	
 
 
 
 
Figure 3. FTIR spectra (a) of non-mineralized (RCP) and mineralized matrices in the 
absence (Ap/RCP) and in the presence of Mg (MgAp/RCP). (b) FTIR spectra of the 
matrices in the region of OCO stretching vibration mode.  
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The surface and structure of designed matrices (RCP, Ap/RCP and MgAp/RCP) were 
evaluated by SEM (Figure 4). Designed matrices revealed heterogeneous porous 
structure with pore size ranging from few microns to 200 µm, as showed by SEM 
images (Figure 4a, b and c). SEM observations of the surface of the matrices at higher 
magnification showed smooth surface for the non-mineralized RCP matrices (Figure 
4d) whereas mineralized matrices provided rough surfaces (Figure 4e and f) due to the 
integration of the mineral phase. Large mineral aggregates, marked with white arrows in 
Figure 4e, were found on the surface of Ap/RCP matrices. 
 
 
 
 
 
 
 
 
 
 
Figure 4. SEM micrographs of RCP (a, d), Ap/RCP (b, e) and MgAp/RCP (c, f) 
matrices at low (a-c) and higher (d-f) magnification.  
 	
SEM observations were confirmed by AFM analysis at the nanoscale level (Figure 5a, b 
and c). 3D AFM image of Ap/RCP matrix (Figure 5b) showed areas non-covered by the 
mineral phase (indicated as RCP), isolated needle-like apatite nanocrystals (Ap) and 
large aggregates of nanocrystals. Conversely, 3D AFM image of MgAp/RCP matrix 
(Figure 5c) showed a surface completely covered by the mineral phase. This 
homogeneous mineral distribution provided a lower surface roughness (74.2±18.2 nm) 
for MgAp/RCP in comparison to that of Ap/RCP (224.1±14.5 nm), as indicated in 
Figure 5d. Material wettability is reported in Figure 6a. The presence of the mineral 
phase enhanced the material wettability since Ap/RCP and MgAp/RCP had a slightly 
lower contact angle than RCP. Nevertheless, all the matrices showed exceptional 
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swelling capacity (around 600 wt.% of water uptake) without statistical difference 
between them (Figure 6b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 3D AFM images of the surface of RCP (a), Ap/RCP (b) and MgAp/RCP (c) 
matrices. d) Mean surface roughness values for each sample measured from two scan 
areas: 2.5x2.5 µm2 and 5x5 µm2. Data are expressed as mean ± SD (n=5). *p<0.05; 
****p<0.0001. e) Surface roughness of titania/PLGA composites and natural bone 
reprinted from Liu H. et al.,18 Copyright (2006) with permission of John Wiley & Sons, 
Inc: Journal of Biomedical Materials Research Part A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Macroscopic properties of non-mineralized (RCP) and Ap/RCP and 
MgAp/RCP mineralized matrices: (a) contact angle and (b) swelling capacity (%). Data 
are expressed as mean ± SD (n = 3). *p<0.05. 
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4.4. Discussion 
Two main goals are accomplished along this chapter. Firstly, prototype scaffolds were 
developed by freeze-drying in order to determine the most suitable mineral/organic 
weight ratio to obtain hybrid scaffolds with homogeneous mineral integration into the 
organic matrix. Once that min/org weight ratio was selected, hybrid matrices were 
developed through mineralization in the presence and in the absence of magnesium 
(Mg) in order to evaluate how Mg incorporation during mineralization can interfere 
final physic-chemical properties. 
As we indicated above, the first goal of this chapter is the preparation of 3D porous 
scaffolds easily handle and not brittle to touch that show homogeneous mineral 
distribution along the scaffold. The highest min/org weight ratio prompted to powdered 
samples (70/30) whereas porous scaffolds were obtained for lower min/org weight ratio 
values. Homogeneous mineral integration into the organic matrix was only appreciated 
for scaffold prototype developed for an initial min/org weight ratio 40/60, which is 
lower than the mineral content in natural bone19 and the mineral content of mineralized 
collagen scaffolds.20 A lower homogenous mineral integration into RCP matrix might 
be associated to the fact that RCP molecules do not self-assembly into large microfibers 
as collagen does21 or due to the lower concentration of charged amino acid groups in 
RCP molecules when compared to collagen since they play a relevant role in controlling 
mineral deposition and growth during bone formation.22,23 Martin et al. indicated that 
58% of the mineral in canine whole bone is intrafibrillar, 14% interfibrillar, and 28% 
from within the gaps between the ends of collagen fibrils.24 Comparing RCP with 
denatured collagen (gelatin), hybrid scaffolds made of gelatin and calcium phosphate 
(mineral content in the range of 10-30 wt.%) have showed an up-regulation of the 
alkaline phosphatase (ALP) and osteocalcin (OC) levels produced by the cells when 
compared to ALP and OC levels of cells cultured on pure gelatin,25-27 indicating the 
osteoconductive effect of composite scaffolds containing lower mineral content than 
native bone. 
The second goal of this chapter aims at understanding how Mg can affect the interaction 
between the mineral and RCP and how it can determine the mineral distribution in the 
organic matrix. FTIR spectra of mineralized matrices showed a shift of vsOCO modes 
from aspartic (contained in RGD sequence) and glutamic acid of the RCP sequence with 
respect to the non-mineralized organic matrix. This shift may be due to the interaction 
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between negatively charged carboxylate groups of RCP and calcium and/or magnesium 
ions.28 The higher shift observed for MgAp/RCP could be due to a stronger interaction 
between the mineral phase and the organic matrix. This can be associated to the fact that 
Mg sites can coordinate and bind water in a higher extent than Ca, thus leading to a 
more effective protein adsorption.29  
Other highly relevant feature of the mineralization process here proposed is the control 
on the surface properties of the mineralized matrices. Until now, most of the designed 
biomimetic scaffolds to support cell and tissue growth have been focused on “bulk 
properties” such as porosity and mechanical response.30 Nevertheless, biomaterial 
surface properties play a crucial role in cell response31 since they mediate specific 
protein adsorption before cells adhere on implants, further regulating cell behaviour and 
dictating tissue regeneration.32 Among biomaterial interfacial properties, it has been 
claimed that surface roughness affects cellular response, enhancing cell adhesion and 
proliferation.33 In this work, relevant differences on mineral distribution and surface 
roughness of designed materials were attributed to the mineralization protocol. The non-
mineralized organic samples (RCP) exhibited smooth surface whereas hybrid matrices 
showed surfaces with higher roughness due to incorporation of the mineral phase into 
the organic matrix. We found that MgAp/RCP matrices showed a homogeneous mineral 
distribution with the surface completely covered by the mineral phase. However, large 
mineral aggregates, isolated Ap nanocrystals and non-covered regions were observed on 
the surface of Ap/RCP matrices. The homogeneous mineral distribution found in 
MgAp/RCP matrices provided mean roughness value closer to that found in biological 
bone (Figure 5e).34 Recent research has indeed suggested that biomaterials with surface 
properties similar to that found in bone aids in the formation of new bone at the 
tissue/biomaterial interface.34 In fact, Webster et al. reported significant increases in the 
initial protein adsorption and subsequent osteoblast adhesion on single-phase nanosized 
ceramic materials when compared with conventional micrometer-sized ceramic 
materials.34,35 Modifications on surface roughness also imply changes in contact angle.36 
Ap/RCP matrices show lower contact angle than MgAp/RCP ones.  
 
4.5. Conclusions 
In this chapter, biomimetic mineralization of recombinant collagen peptide (RCP) has 
been carried out at increasing initial theoretical mineral/organic weight ratio in order to 
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determine the most suitable mineral content to obtain hybrid scaffolds with 
homogeneous mineral integration. Scaffold prototype containing a 40 wt.% of mineral 
was selected as the best condition due to homogeneity of the sample as well as good 
mineral integration. Then, hybrid matrices with 40 wt.% of mineral content were 
prepared to evaluate the effect of introduction of magnesium (Mg) during 
mineralization on the interfacial properties of designed biomaterial. SEM and AFM 
imaging showed an homogeneous mineral distribution on the RCP matrix mineralized 
in presence of Mg, which provided a surface roughness similar to that found in bone. 
Furthermore, hybrid matrices showed exceptional swelling properties. The results 
indicated that biomimetic mineralization of recombinant collagen peptide is a promising 
approach for the development of scaffolds for bone regeneration (Chapter 6). 
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Chapter 5: Investigations of different crosslinking approaches 
of mineralized recombinant collagen peptide 
 
5.1. Introduction 
Mineralization of recombinant collagen type I derived peptide (RCP) containing RGD 
sequences provided hybrid structures with similar physic-chemical features than bone 
extracellular matrix (ECM). However, one of the main drawbacks of the use of RCP is 
the fast degradation and total dissolution under physiological conditions. 3D structure 
for bone regeneration should maintain mechanical stability during in vivo bone 
remodelling and simultaneously undergo degradation to allow the ultimate replacement 
by newly formed bone.1 To improve the resistance to the degradation as well as the 
mechanical performance of different polymers/proteins/peptides used in biomedical 
field, different crosslinking methodologies have been adopted. The crosslinking 
methods can be divided in three main groups: i) physical methods (e.g., dehydrothermal 
treatment (DHT) or ultraviolet and gamma irradiation);2-4 ii) chemical methods using 
crosslinking agents such as glutaraldehyde (GA)5,6 and diisocyanates, carbodiimides7-9 
(e.g., 1-ethyl-3-(3-dimethylamino propyl) carbodiimide hydrochloride (EDC) and n-
hydroxysuccinimide (NHS)), polyepoxy compounds10,11 (e.g., 1,4-butanediol diglydicyl 
ether (BDDGE) and glycidyl isopropyl ether (PGE)) and acyl azide methods12,13 and iii) 
biological methods14,15 (e.g., transglutaminase). Most of the chemical crosslinking 
agents are highly cytotoxic and may impair the biocompatibility of the crosslinked 
biomaterials. Therefore, much interest is now directed toward naturally derived 
crosslinking reagents presenting lower cytotoxicity. 
Genipin is an aglycone derived from an iridoid glycoside called geniposide present in 
fruit of Gardenia jasminoides Ellis. It is obtained from its parent compound, geniposide, 
via enzymatic hydrolysis with β-glucosidase.16 Several works demonstrated that genipin 
reacts with materials containing primary amine groups, such as collagen, chitosan, 
gelatin, peptides and polypeptides, to form covalently crosslinked networks.17-20 It has 
been proposed that the crosslinking mechanism consists of two reactions, involving 
different sites on the genipin molecule (Figure 1).21 Reaction scheme I corresponds to 
the nucleophilic substitution reaction that involves the replacement of the ester group on 
the genipin molecule by a secondary amide linkage. By the time that the ester 
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Reaction Scheme 1 
Reaction Scheme 2 
substitution occurred, it is believed that the other half of the crosslinked have already 
formed following reaction scheme 2 (Figure 1).21 This reaction starts with an initial 
nucleophilic attack of the genipin C3 carbon atom from a primary amine group to form 
an intermediate aldehyde group. The newly formed secondary amine reacts with the 
aldehyde group to form a heterocyclic compound. Once that the heterocyclic compound 
has formed, oxygen radical-induced polymerization of genipin occurs, given the sample 
a blue colour.  
 
 
 
           
 
 
 
 
Figure 1. Proposed crosslinking reactions involving genipin and amine groups of 
collagen-based biomaterials. Reprinted from Butler et al.,21 Copyright (2003), with 
permission from Wiley Periodicals, Inc., A Wiley Company: Journal of Polymer 
Science Part A: Polymer Chemistry. 
 
In vitro evaluation of cytotoxicity of genipin showed that the cellular compatibility of 
the genipin-fixed tissue was superior to its glutaraldehyde-fixed counterpart.22 It was 
reported that genipin is about 5,000–10,000 times less cytotoxic than glutaraldehyde.23 
Yao et al.24 also found that if the concentration of genipin is lower than 0.5 wt.%, the 
risk of cytotoxicity could be avoided. Ceramic composed of gelatin and genipin has 
been tested as bone substitute in rabbit calvarial bone.25 This material showed a good 
biocompatibility, osteoconductivity and biodegradability with a progressive 
replacement of the composite for new bone. Indeed, genipin can be used in a broad 
range of applications including personal care, cosmetics, dietary supplements, 
packaging, textiles, beverages, foodstuffs, drugs and animal feeds.26  
The other crosslinking method evaluated along this chapter is dehydrothermal treatment 
(DHT). DHT is a thermal process able to induce ester and amide bonds among collagen 
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macromolecules via condensation reactions when collagen is subjected to increased 
temperature (>98.8°C) under vacuum (Figure 2). An advantage of DHT crosslinking is 
that it does not involve the use of cytotoxic reagents.27  
 
 
 
 
Figure 2. Scheme of reaction during DHT treatment. Reprinted from Haugh et al.,27 
Copyright (2011), with permission from Mary Ann Liebert, Inc.:	 Tissue Engineering 
Part A. 
 
On one hand physical treatment can present lower cytotoxicity but it can also promote 
lower crosslinking degree. On the other hand, the chemical treatment provides higher 
crosslinking degree but it can provoke change in the scaffold structure and further 
cytotoxic effects. The selection of a suitable crosslinking technique for the hybrid RCP 
scaffolds is the main issue of this chapter. 
Herein, we prepared genipin-crosslinked scaffolds by three different methodologies in 
order to select the most feasible technique and the most suitable genipin concentration. 
Then, non-mineralized (RCP) and mineralized (Ap/RCP and MgAp/RCP) scaffolds 
were chemically crosslinked with genipin and compared with the physically crosslinked 
scaffolds by DHT through the assessment of the crosslinking degree, the degradation 
rate and the enzymatic resistance of crosslinked scaffolds (described in Chapter 2).  
5.2. Methods 
The chemical crosslinking with genipin was carried out by three different techniques, as 
shown in Figure 3: 
a. Pre-crosslinking: RCP was crosslinked before mineralization. Genipin was 
added directly to RCP solution and stirred at 50 ºC during three hours. After that, 
mineralization was carried out following the protocol previously described in 
Chapter 3. After 2 hours of mineralization, the crosslinked-mineralized slurry was 
freeze-dried. 
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b. Post-crosslinking: RCP was crosslinked after mineralization. RCP 
mineralization was carried out following the protocol previously described in 
Chapter 3. After 2 hours of mineralization, genipin solution was added to 
mineralized slurry, stirred vigorously and kept two days at room temperature. After 
that, the sample was freeze-dried. 
 
c. Scaffold crosslinking: Fabricated scaffolds were crosslinked by immersion in 
genipin solution. In the case of hybrid scaffolds, firstly mineralization was carried 
out, then mineralized slurry was freeze-dried and finally mineralized scaffolds were 
crosslinked by immersion in genipin solution. Then, scaffolds were washed with 
Milli-Q water and dried into the oven at 40 ºC. Considering that RCP is water 
soluble, genipin concentration as well as composition of genipin solvent were 
optimized (Table 1). 
 
 
 
 
 
 
 
 
Figure 3. Different techniques to chemically crosslink scaffold with genipin. 
 
Table 1. Divisions of the conditions of crosslinking of RCP by scaffold 
immersion into genipin solution.  
 
Genipin concentration (wt.%) Water/Ethanol 
0.05 0/100 
0.125 90/10-70/30-50/50-30/70-10/90-0/100 
0.25 0/100 
0.5 0/100 
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DHT treatment of RCP scaffolds was carried out at 160 °C for 48 hours under 
vacuum.28  
5.3. Results 
5.3.1. Chemical crosslinking with genipin  
Figure 4 displays the macroscopic view of the pre- and post-crosslinked mineralized 
RCP samples. Pre-crosslinked samples (Figure 4a) showed a homogeneous blue colour 
that may indicate the homogeneity of the sample after mineralization and crosslinking. 
On the other hand, post-crosslinked samples (Figure 4b) showed the formation of two 
phases: i) a phase of dark blue colour at the top of the solution mainly composed by 
crosslinked non-mineralized organic matrix and ii) a phase with yellow-orange colour 
that may belong to mineralized RCP suspension with lower crosslinking degree. After 
freeze-drying the slurries, the respective scaffold structure and composition was 
analysed by SEM and TGA. SEM images of the scaffold surface (at the base-middle 
zones) showed the presence of larger aggregates in the surface of pre-crosslinked 
samples whereas homogeneous mineral integration was observed for the post-
crosslinked samples. On the other hand, the thermogravimetric analysis indicated a 
significant heterogeneity for post-crosslinked samples containing only organic phase at 
the top of the scaffolds (Figure 4c, PostT). TGA curve of pre-crosslinked samples 
(Figure 4c) also verified the heterogeneous composition of the obtained hybrid scaffolds 
with a higher mineral content at the base (~50 wt.%) respect to the top of the scaffold 
(~30 wt.%). 
 
 
 
 
 
 
 
Figure 4. Image of pre (a) and post-crosslinked (b) RCP mineralized slurry before 
freeze-drying and SEM images of the surface of scaffolds obtained after the freeze-
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drying protocol. (c) TGA curves of the top (T) and base (B) of non-crosslinked (NC), 
pre-crosslinked (Pre) and post-crosslinked (Post) hybrid scaffolds.  
 
 
Taking into account the drawbacks of pre- and post-crosslinking methodologies, we 
decided to carry out the crosslinking and mineralization individually in a two-step 
protocol named as scaffold crosslinking (Figure 3). Considering that RCP is water 
soluble, firstly we evaluated the composition of the genipin solvent to determine the 
most suitable volume ratio of water/ethanol (v/v) to avoid scaffold dissolution and loose 
of the structure (Figure 5). Secondly, several concentrations of genipin were assessed 
(Figure 6). For the first aim, scaffolds were immersed in genipin solutions with fixed 
genipin concentration (0.125 wt.%) and increasing ethanol contents (Table 1). After 48 
hours, scaffolds were completely dissolved for crosslinking experiments in genipin 
solutions in 10, 30 and 50 % (v/v) of ethanol. For scaffold crosslinking in genipin 
solution in 70 % (v/v) ethanol, scaffolds degraded partially as indicated the blue colour 
of genipin solution due to release of RCP molecules that continued to react with genipin 
(Figure 5). On the other hand, scaffolds crosslinked in genipin solutions in 90 % (v/v) 
of ethanol kept the macroscopic structure without release of RCP molecules as indicated 
by transparent colour of the genipin solution (Figure 5). After crosslinking, scaffolds 
were washed with water and dried into the oven at 40 °C. SEM images of scaffolds 
before and after crosslinking in genipin solution in 90 % (v/v) of ethanol (Figure 5) 
indicated no changes in the scaffold structures after crosslinking. It means that it is not 
necessary a secondary freeze-drying to recover porous structure which simplifies the 
system for future scale-up of the process. 
 
 
 
 
 
 
 
 
 
Figure 5. Optical microscopy images of crosslinked structures after 48 hours immersed 
in genipin (0.125 wt.%) aqueous solution with increasing ethanol content (%, v/v). 
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Scale bar: 500 mm. SEM images of RCP scaffolds before and after crosslinking by 
immersion in genipin (0.125 wt.%) solution in aqueous/ethanol volume ratio 10/90. 
 
The next step is to evaluate the most suitable genipin concentration. Scaffolds were 
crosslinked by immersion in 2 mL of ethanol (90 % v/v) containing different 
concentrations of genipin (0.05, 0.125, 0.25 and 0.5 wt.%). After 24 hours, scaffolds 
immersed in solution with the lowest genipin concentration showed yellow colour 
whereas the rest of scaffolds showed dark blue colour (Figure 6a). After 48 hours, all 
the scaffolds showed dark blue colour. The dark-blue coloration of the scaffolds is 
associated with the oxygen radical-induced polymerization of genipin as well as its 
reaction with amino groups.21  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Images of scaffolds after 24 hours (a) and 48 hours (b) of crosslinking in 
increasing genipin concentrations in aqueous ethanol solution (90 % v/v ethanol); (c) 
Swelling capacity of crosslinked scaffolds at increasing genipin concentrations and (d) 
crosslinking degree of RCP scaffolds after crosslinking with increasing genipin 
concentrations. Data are expressed as mean ± SD (n=3).  
 
After 48 hours of crosslinking, scaffolds were washed to eliminate non-reacted genipin 
and dried. The swelling capacity of crosslinked scaffolds with different genipin 
concentrations upon exposure to PBS (pH 7.4) at 37 °C for 24 hours is shown in Figure 
6c. It was found that RCP scaffolds crosslinked with the lowest genipin concentration 
showed the lowest capacity to absorb water. Figure 6d displays the extent of 
crosslinking of the scaffolds calculated by TNBS assay. The crosslinking degree of the 
scaffolds crosslinked with different genipin concentrations was roughly the same 
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(around 70%) except for the scaffolds crosslinked with the highest genipin 
concentration that showed a higher extent of crosslinking (88%). Considering the 
swelling properties, the crosslinking extent and the possible cytotoxic effects due to the 
use of high genipin concentrations, 0.125 wt% of genipin in 90% (v/v) ethanol solution 
was selected as crosslinking protocol for the further studies. 
 
5.3.2. Investigations of different crosslinking of RCP hybrid scaffolds 
Chemical crosslinking technique with genipin is compared respect to physical 
crosslinking by DHT through the assessment of the crosslinking degree, the stability 
under physiological conditions and the enzymatic resistance of crosslinked scaffolds. 
This study is carried out for the three scaffold compositions evaluated until now: non-
mineralized scaffolds (RCP), mineralized scaffolds (Ap/RCP) and mineralized in the 
presence of magnesium (MgAp/RCP).  
The figure 7 displays the extent of crosslinking of RCP, Ap/RCP and MgAp/RCP 
scaffolds crosslinked by the two different methodologies. The scaffolds crosslinked 
with genipin showed a higher crosslinking extent when compared to scaffolds with 
same composition, but crosslinked by DHT (p<0.0001). Respect to scaffold 
compositions, non-mineralized scaffolds (RCP) showed the highest crosslinking extent 
for both crosslinking techniques whereas MgAp/RCP scaffolds showed the lowest 
value.  
 
 
 
 
 
 
 
 
 
Figure 7. Crosslinking degree of three scaffold compositions (RCP, Ap/RCP and 
MgAp/RCP) crosslinked by two different techniques: genipin and DHT. Data are 
expressed as mean ± SD (n=3). ****p<0.0001. 
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The stability of the crosslinked scaffolds under physiological conditions was evaluated 
up to 28 days in PBS at 37 °C (Figure 8). From macroscopic observation, there was no 
loss of shape or weakening of structural architecture of the scaffolds after this period. 
RCP scaffolds crosslinked by DHT showed negative weight loss due to gain of weight 
for the precipitation of salts that were not well removed during washing of the scaffold. 
MgAp/RCP scaffolds crosslinked by DHT or genipin showed the highest weight loss 
(7.9±0.6 and 10.2±3.6 wt.%, respectively) after 28 days in PBS. The degradation test 
did not indicate relevant differences on the weight loss of scaffolds with same 
composition differing on crosslinking methodology. Overall, more than 90 wt.% of 
weight of scaffolds remained after 28 days in PBS as well as its structure did not suffer 
any alteration, indicating the effectiveness of crosslinking techniques. 
 
 
 
 
 
 
 
 
Figure 8. Weight loss of crosslinked scaffolds (RCP, Ap/RCP and MgAp/RCP) after 28 
days of immersion in PBS medium at 37 °C. Data are expressed as mean ± SD (n=3). 
 
In vitro degradation studies were carried out in the presence of bacterial collagenase 
from Clostridium histolyticum. Figure 9a displays the weight loss of crosslinked 
scaffolds after 1 day in collagenase solution. The RCP release to the medium due to 
scaffold degradation was also evaluated by protein quantification (Figure 9b). RCP and 
MgAp/RCP scaffolds crosslinked with genipin were completely dissolved after 24 
hours in collagenase solution whereas Ap/RCP scaffolds crosslinked with genipin kept 
the structure presenting a weight loss of 11.4±2.4 wt.%. This weight loss is associated 
to release of RCP to the medium, which is around the 40% of the organic component of 
the scaffold. Ap/RCP scaffolds crosslinked by DHT showed a higher resistance to 
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enzymatic degradation compared to genipin, as indicated the negative weight loss and 
the lower protein release to the medium after 24 hours in collagenase solution. Unlike 
RCP scaffolds crosslinked with genipin, RCP scaffolds crosslinked by DTH showed a 
higher resistance to enzymatic degradation with a small percentage of RCP molecules 
released to the medium (Figure 9b). On the other hand, MgAp/RCP scaffolds 
crosslinked by DHT showed a completely degradation (100 wt.% weight loss) after 24 
hours in collagenase solution (Figure 9a). 
 
 
 
 
 
Figure 9. Enzymatic degradation of crosslinked scaffolds after 24 hours in Tris-HCl 
solution containing collagenase: (a) weight loss and (b) protein release. Data are 
expressed as mean ± SD (n=3). *** p<0.001 and ****p<0.0001. 	
5.4. Discussion 
An ideal scaffold for bone tissue engineering should maintain the structure and 
mechanical stability in order to guide the development of new bone formation and 
simultaneously it might present a suitable biodegradation to be absorbed by the 
surrounding tissue allowing the ultimate replacement by new formed bone without the 
need for surgical removal. The aim of this chapter is to investigate the crosslinking of 
RCP molecules in order to enhance stability of scaffolds under physiological conditions 
for the long-term biomedical applications. Two different crosslinking methodologies are 
evaluated: genipin, a natural chemical crosslinking agent with low cytotoxicity and 
dehydrothermal crosslinking, previously used for the crosslinking of RCP28 and also for 
crosslinking of hybrid scaffolds.8,29  
In previous studies, the crosslinking of collagen/gelatin biomaterials with genipin has 
been carried out by different methodologies: i) scaffold crosslinking by immersion of 
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scaffold in genipin solution in PBS and the further freeze-drying,30 ii) gel-crosslinking 
by immersion of gelatin hydrogel (4 °C) in genipin solution31 and iii) mixing 
crosslinking32 by adding genipin solution to polymer and keeping under stirring for a 
specific time interval. Despite the fact that most of hybrid scaffolds developed for bone 
regeneration were crosslinked, low number of works has investigated how the mineral 
phase can affect to the crosslinking reaction. 
In this study, three different methodologies have been evaluated for chemical 
crosslinking of RCP with genipin. We have proposed the mixing crosslinking by adding 
genipin to RCP solution before the mineralization (pre-crosslinking) in order to have 
more available amine groups for the crosslinking. However, after freeze-drying, hybrid 
scaffolds showed heterogeneous composition and the formation of larger aggregates 
that may indicate that pre-crosslinking interfered in the mineralization of RCP 
molecules. To overcome this shortcoming, genipin was added after RCP mineralization 
(post-crosslinking). However, during crosslinking reaction (48 hours), mineral phase 
tent to sediment while genipin mainly reacted with non-mineralized RCP molecules 
present at the top triggering to the formation of a two-phase composite material. 
Therefore, and considering the drawbacks of mixing crosslinking, we decided to 
investigate the scaffold crosslinking by immersion in genipin solution. Considering that 
RCP is water soluble, genipin was dissolved in aqueous solutions at increasing ethanol 
contain. We selected genipin solution in 90% (v/v) ethanol for the crosslinking of 
scaffolds since scaffolds kept the structure and did not dissolve after 48 hours of 
crosslinking, avoiding a secondary freeze-drying process. The other advantage of this 
method is the possibility of washing the scaffolds after the crosslinking procedure in 
order to remove the non-reacted genipin that can promote cytotoxic effect of the 
designed biomaterial. Respect to the concentration of genipin, RCP scaffolds 
crosslinked by immersion in genipin solution (0.125 wt.%) provided a 70% of 
crosslinking extent, similar to the crosslinking extent on genipin-crosslinked 
chitosan/collagen33 or gelatin17 scaffolds/films. The crosslinked scaffolds with these 
parameters also showed exceptional swelling properties. 
The next aim is to compare the chemical versus the physical crosslinking of hybrid 
scaffolds. For the three scaffold compositions (RCP, Ap/RCP and MgAp/RCP), the 
highest extent of crosslinking was achieved for the scaffolds crosslinked with genipin. 
A lower extent of crosslinking for scaffolds crosslinked by DHT may be related to the 
fact that DHT is a zero-length crosslinking in which amide bonds are directly formed 
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between adjacent amine and carboxylic groups without any bridging molecule being 
incorporated in the network.34 On the other hand, genipin may bridge between peptide 
chains that have a distance up to 1.6-2.5nm, by introducing a dimeric genipin-spacer 
with a cyclic structure. Moreover, genipin molecules may be polymerized before 
crosslinking amino groups, by introducing an oligomeric-genipin spacer.35  
For both crosslinking methodologies, mineralized scaffolds showed lower extent of 
crosslinking compared to non-mineralized ones. This effect can be associated to the 
presence of the mineral phase since calcium and phosphate ions interact electrostatically 
with carboxylic and amine groups of RCP, reducing the number of amine and 
carboxylic groups available for the crosslinking reaction. In fact, MgAp/RCP scaffolds 
crosslinked by DHT showed the lowest extent of crosslinking that can be associated to a 
stronger interaction (more than in Ap/RCP scaffolds) between carboxylic groups of 
RCP and calcium and magnesium ions of the mineral phase (as previously demonstrated 
in chapter 4) hindering the crosslinking reaction. Lower crosslinking extent explained a 
higher degradation of MgAp/RCP scaffolds under physiological conditions. In general, 
all the scaffold compositions crosslinked by genipin or DHT showed good stability 
under physiological conditions (weight loss <10wt.%).  
On the other hand, the enzymatic resistance of crosslinked scaffolds seemed not to be 
dependent on the crosslinking extent. Scaffolds with the highest crosslinking extent 
(RCP crosslinked with genipin) showed a completely degradation after 24 hours in 
collagenase solution whereas crosslinked Ap/RCP scaffolds (with lower extent of 
crosslinking than RCP scaffolds) showed the highest enzymatic resistance. These 
results are contrary to previous studies in literature that indicated that chemical 
crosslinking (EDC/NHS) showed higher enzymatic resistance than physical 
crosslinking techniques.8  
5.5 Conclusions 
In this study, crosslinking of hybrid structures have been carried out by two different 
techniques, genipin and DHT. The chemical crosslinking with genipin has been set-up 
in order to avoid interfering the mineralization mechanism of RCP. Genipin 
concentration as well as genipin solvent has been selected taking into account the 
removal of a secondary freeze-drying process, the crosslinking degree and the water 
uptake capacity of designed scaffolds. The highest extent of crosslinked was achieved 
for scaffolds (independently of the scaffold composition) crosslinked with genipin. 
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Nevertheless, the results indicated that the presence of the mineral phase might hinder 
the crosslinking reaction since lower crosslinking degree was obtained for hybrid 
scaffolds. Even if crosslinked scaffolds either by genipin or DHT showed a good 
stability under physiological conditions, the scaffolds crosslinked by DHT were 
endowed with a higher enzymatic resistance. The results highlight, for the first time, the 
effect of the mineral phase hindering the crosslinking reactions and therefore 
diminishing scaffold stability. In this case, due to higher enzymatic resistance, DHT 
was selected as crosslinking methods of RCP hybrid scaffolds for bone regeneration.  
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Chapter 6: Fabrication of 3D isotropic hybrid scaffolds 
through freeze-drying and evaluation of their osteoinductive 
potential 
 
6.1. Introduction 
The previous work was focused on the study of biomineralization of recombinant 
collagen peptide (RCP) in order to achieve chemical composition similar to bone. For 
this purpose, the introduction of foreign ions such as magnesium was carried out to 
improve osteoinductivity. On the other hand, for bone tissue engineering, the 
optimization of scaffold structure has also a large impact on the final outcome. 
Scaffolds must encourage the diffusion of cells and nutrients while maintaining 
adequate mechanical properties.1 Moreover, scaffolds should be biocompatible and 
meet biodegradability at a commensurate rate with remodelling. 
The porosity of a material is defined as the percentage of void space in a solid2 and it is 
a morphological property that is independent of the material. In bone tissue regeneration 
it has been proved that more tissue ingrowth and new bone formation occurred in the 
areas with higher porosity after implantation in rabbit craniums.3 Moreover, the pores 
are necessary for bone tissue formation because they allow cell migration and 
proliferation from surrounding bone tissues to the inner areas of the scaffolds, as well as 
the vascularization.4 Pore size greater than 200 µm has been proposed as the minimum 
required for bone formation and capillary innervation, with 400 µm as an upper limit 
due to mechanical stability.1,5,6 Furthermore, the interconnections between pores within 
the scaffold structure are also an important aspect of porosity, and an interconnect size 
below 100 µm restricts bone regeneration.7 Bone-like scaffold can be generally divided 
into two groups: sponge-like scaffold mimicking trabecular bone consisting in an 
isotropic structure that exhibits high porosity and parallel aligned pore scaffold 
resembling cortical bone.  
Several technologies have been used to create porosity in a biomaterial, such as salt 
leaching, gas foaming, phase separation, ice-templating and sintering.8 The ice-
templating includes any technique that utilizes ice to form a three-dimensional structure 
(i.e., freeze-drying and freeze casting). The technique consists in the freezing of a 
water-based solution that begins on ice nucleation within the solution and the 
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concentration of the solute in the regions between the growing crystals. Then, the ice is 
removed via sublimation and the solute remains in a porous structure than can be either 
isotropic or anisotropic. In fact, the final porous structure relies on the variables that 
influence ice nucleation and growth (Figure 1). The type and concentration of solutes 
within the solution and the set cooling rate before freezing can be altered during 
nucleation. After nucleation, crystal growth and annealing processes, such as Ostwald 
ripening, determine the features of the final scaffold. Several parameters such as set 
freezing temperature, freezing rate as well as concentration of solute will affect ice 
crystal growth and so the final scaffold structure.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A flow chart summarizing the key points for the design of scaffold structure 
and the variables of the process that allow tailoring the scaffold porosity. Reprinted 
from Pawelec et al.,9 Copyright (2014) with permission from AIP Publishing LLC: 
Applied Physics Reviews. 
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The objective of the present chapter is to design bioactive, biofunctional and 
biodegradable 3D scaffolds for bone tissue regeneration through biomimetic 
mineralization of RCP and freeze-drying. We focused on the design of sponge-like 
scaffold with isotropic and high porosity mimicking cancellous bone. The effect of 
mineral phase on scaffold pore size, porosity, permeability and mechanical properties 
was evaluated. Furthermore, the in vitro kinetic degradation of mineralized scaffolds 
was evaluated to determine the ion release (Ca2+ and Mg2+) to the cell medium since 
they might affect to cellular behaviour.10 The ultimate point, the in vitro response of 
mesenchymal stem cells (MSCs) to the biochemical and biophysical cues provided to 
the scaffolds by biomimetic mineralization is investigated in terms of cell adhesion, 
proliferation, migration and further expression of osteogenic related markers.  
6.2. Methods 
6.2.1. Scaffold preparation  
Firstly, the conventional (without magnesium) mineralization of RCP was carried out as 
previously described in Chapter 3 (same preparation than RCPAp sample). Then, 
mineralized slurry was freeze-dried to obtain 3D structures. As we described above, 
several parameters can be adjusted during the freezing process in order to obtain 
isotropic porous structure with suitable pore size. Herein, we evaluated: 
• Mould: Teflon mould or well-plate. Teflon mould has a thicker bottom part that 
restricts the thermal conductivity prompting different thermal profile inside the 
slurry affecting nucleation and growth of ice and so pore structure. 
• Freezing temperature: at higher freezing temperature, larger pores are obtained. 
• Solid content: Higher solid content prompts to dense scaffolds with lower 
porosity. 
 
The frozen samples were freeze-dried with a heating ramp of 5°C/h under vacuum (0.1 
mbar) (5Pascal, Cinquepascal srl, Italy). The porous structures obtained under the 
conditions (summarized in Table 1) were assessed by SEM. Once that the conditions of 
freeze-drying have been selected, 3D isotropic scaffolds of three different compositions 
were developed: non-mineralized ones (RCP), mineralized in the absence of magnesium 
(Ap/RCP) and mineralized in the presence of magnesium (MgAp/RCP). Cylindrical 
scaffolds of 8 mm in diameter and 5 mm of height were obtained by cutting with a 
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biopsy puncher (HS Biopsy punch 8 mm, HShospitalService, Italy). Then, scaffold 
stability and degradability rate was adjusted by physical crosslinking via 
dehydrothermal treatment at 160 °C for 48 hours under vacuum (0.001 mbar).11 All 
scaffolds were sterilized by autoclave before in vitro degradation studies and in vitro 
tests.  
 
Table 1. Variables and parameters tested for the design of isotropic porous scaffolds 
through freeze-drying of mineralized slurry. 
 
Mould Tfreezing, °C Solid Content, wt.% 
Teflon 
-80 12.5 
10.0 
-40 12.5 
10.0 
-20 12.5 
10.0 
Well-Plate 
-40 12.5 
10.0 
-20 12.5 
10.0 
7.0 
 
6.2.2. Cell culture and cell seeding on scaffolds 
Mouse mesenchymal stem cells (C57BL/6) (MSCs), purchased from Invitrogen 
(Carlsbad, CA), were cultured in standard tissue culture flask and maintained in 
standard cell culture Dulbecco Modified Eagle’s Medium (DMEM, Gibco) 
supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) 
penicillin/streptomycin (Pen/Strep; 100 U ml-1/100 µg ml-1) at 37 °C with 5% CO2. 
Cells were detached from culture flasks by trypsinization, centrifuged and resuspended. 
Cell number and viability were assessed with the trypan-blue dye exclusion test. Before 
cell seeding, sterilized scaffolds were pre-incubated overnight with standard cell culture 
medium (1.5 mL). Then, the scaffolds were replaced in a 24-well plate and each one 
was seeded by carefully dropping 30 µL of cell suspension containing 5.0 x 104 cells 
onto the upper surface, allowing cell attachment for 30 min at 37 °C with 5% CO2 
before adding 1.5 ml of cell culture medium. MSCs were incubated in osteogenic 
medium consisting in α-MEM media supplemented with 10% (v/v) FBS, 1% (v/v) 
Pen/Strep, 10 mM β-glicerofosfato, 50 µg/ml L-ascorbic acid and 100 nM 
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dexamethasone and under standard conditions (37 °C, 5% CO2) for up to 28 days (time 
points: 1, 3, 7, 14, 21 and 28 days). Culture medium was partially changed every three 
days. All the cell-handling procedures were performed in a sterile laminar flow hood. 
Cell viability and proliferation, cell morphology, cell migration, gene expression by 
quantitative real-time polymerase chain reaction, western blot analysis and 
immunofluorescence, were carried out as described in chapter 2. 
6.3. Results 
6.3.1. Design of 3D structures through freeze-drying 
Table 2 shows the SEM images of the longitudinal and transversal section from the 
scaffolds fabricated in Teflon mould using different freezing temperatures. The increase 
of the pore size due to the increasing final freezing temperature was clearly evident (see 
SEM images of transversal section at higher magnification). The scaffolds fabricated by 
freezing at -80 °C in the freezer and -40 °C in the shelf of the freeze-drier showed 
aligned porous structure. On the other hand, scaffolds obtained by freezing at -20 °C 
showed heterogeneous porous structure composed of areas where ice crystal grew 
preferentially along longitudinal direction triggering to aligned pores and others regions 
where ice crystals grew in all the directions prompting to random pore orientation. SEM 
images may indicate that freezing using Teflon mould preferably induced aligned 
porous structures. Unlike the teflon mould, scaffolds fabricated in well-plate did not 
show aligned porous structures as indicated SEM images of longitudinal section (Table 
3). More homogeneous porous structures were obtained for scaffolds fabricated by 
freezing at -20 °C in the freezer compared to scaffolds frozen in well plate inside 
freeze-drier (-40 °C). Among the scaffolds fabricated at -20 °C, homogeneous isotropic 
porous structure were obtained for solid content of 10 wt.% and 7 wt.%. The lowest 
solid content prompted to larger pores. Considering the isotropic porous structure and 
the suitable pore size, this condition was selected to prepared 3D scaffolds. 
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Table 3. SEM images of longitudinal and transversal section of 3D scaffolds designed 
by freeze-drying mineralized slurry in well plate at -40 °C in freeze-drier (B) and -20 °C 
in freezer (A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.3.2. Characterization of physic-chemical properties of designed 3D scaffold 
The XRD pattern of non-mineralized scaffolds (RCP) exhibited a broad band belonging 
to organic phase whereas XRD pattern of mineralized scaffolds (Ap/RCP and 
MgAp/RCP) showed reflections ascribed to HA (ASTM card file No 9-432) (Figure 
2a). The peaks were rather broad in both patterns indicating low crystallinity and nano-
sized dimensions of the diffracting crystal domains obtained through the RCP 
biomimetic mineralization. In fact, FTIR spectrum of MgAp/RCP scaffolds (Figure 2b) 
also exhibited broad and relatively featureless phosphate bands indicating lower 
crystallinity of the mineral phase compared to Ap/RCP scaffold, as it is reported by the 
index for crystallinity degree calculated from FTIR spectra (splitting factor, Table 
4).12,13 All FTIR spectra showed the presence of amide bands belongs to RCP: amide I 
(1637 cm-1), amide II (1542 cm-1) and amide III (1242 cm-1).14 FTIR spectra of 
mineralized scaffolds also showed the ν2 vibration mode of CO32- group at 873 cm-1 that 
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corresponds with B-type carbonation (substitution of PO4 by CO3).15 The absence of the 
peak at 880 cm-1 (associated to A-type carbonation) could indicate that the carbonation 
can be assigned only to the B position. In fact, previous studies of the mineral phase 
along the chapter 3 revealed the B-type carbonation for synthesized apatites that was 
associated to the carbon dioxide surrounding the reaction vessel or to the presence of 
CaCO3 impurities in the reactants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. XRD (a), FTIR spectra (b) and SEM micrographs (c) of longitudinal and 
transversal section of RCP, Ap/RCP and MgAp/RCP scaffolds. Scale bar = 250 µm.  
 
The carbonation of the as-synthesized apatite may explain the fact the Ca/P ratio of 
mineral phase was higher than stoichiometric hydroxyapatite (Ca/P>1.67) (Table 4). 
The Mg/Ca molar ratio of MgAp/RCP scaffolds reached 1.29 wt.% in respect to the 
total scaffold weight (Table 4), which was slightly higher than the magnesium content 
reported for biological bone apatite.16  
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Table 4. Chemical composition of mineralized scaffolds analysed by ICP-OES (a). 
Splitting factor calculated from FTIR spectra of mineralized scaffolds (b).13 Data are 
expressed as mean ± SD of three samples (n=3).  
Sample Ca 
(mol)a 
P 
(mol)a 
Ca/P 
(mol)a 
Mg 
(wt.%)a 
Mg/Ca 
(% mol) a 
SFb 
RCP 0.01±0.01 0.00±0.00 ------- ------ ------ ----- 
Ap/RCP 0.39±0.01 0.21±0.00 1.83±0.04 0.10±0.02 ----- 2.37±0.04 
MgAp/RCP 0.37±0.00 0.20±0.00 1.87±0.01 1.29±0.00 14.4±0.06 2.09±0.03 
 
Respect to scaffold microstructure, SEM observations clearly showed homogeneous 
pore structures in all the 3 scaffold compositions (Figure 2c). Large spherical pores 
were evenly distributed and well stacked along longitudinal and transversal section. 
Moreover, small pores could be seen on the walls of the large ones indicating good 
interconnectivity. The scaffolds exhibited a mean pore size close to 250 µm in all the 
cases (Table 5). On the other hand, mineralized scaffolds (Ap/RCP and MgAp/RCP) 
exhibited lower porosity (≈86% and 83%, respectively) when compared to non-
mineralized one (≈92%) (Table 5). This effect is associated with an increase of the solid 
loading (e.g., concentration of the nanoparticles) that promotes a decrease of the 
resulting scaffold porosity.17,18 Scaffold permeability was evaluated by falling head 
method (described in Chapter 2). RCP and MgAp/RCP scaffolds showed similar 
permeability (7·10-6 m2) whereas it decreased up to 4·10-6 m2 for Ap/RCP scaffolds 
(Table 5). Moreover, scaffold mechanical properties were measured by dynamic 
mechanical analysis (DMA, Chapter 2). Contrary to what might be expected, RCP 
scaffolds showed the highest young modulus whereas mineralized scaffolds showed 
lower values (Table 5). In fact, young modulus decreased approximately a threefold and 
seven fold for Ap/RCP and MgAp/RCP scaffolds, respectively. 
Table 5. Macroscopic scaffolds properties: mean pore size of dried scaffolds calculated 
form SEM images (n=60), porosity calculated by gravimetry method (n=5), 
permeability determined by head falling method (n=5) and young modulus analysed by 
DMA (n=5). Data are expressed as mean ± SD. 
Sample Mean Pore Size 
(µm) 
Porosity 
(%) 
Permeability 
10-6 (m2) 
Young Modulus  
(KPa) 
RCP 260±65 92.2±0.4 7.25±1.15 174±40 
Ap/RCP 226±51 86.5±0.6 4.01±0.29 68±15 
MgAp/RCP 242±54 83.3±0.5 7.91±1.21 23±2 
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6.3.3. Evaluation of in vitro degradation of the scaffolds 
The in vitro degradation of the scaffold was evaluated by quantification of the mass loss 
as well as the ion release from the scaffold under physiological condition (Figure 3). 
The weight of RCP and Ap/RCP scaffolds remained nearly constant along 28 days 
whereas the weight of MgAp/RCP scaffolds slightly decreased after 28 days in PBS 
(Figure 3a). The overall mass loss for the three scaffold compositions was very low thus 
indicating good scaffold stability under physiological conditions. Moreover, ion release 
quantified by ICP-OES analysis indicated that MgAp/RCP scaffolds showed a faster ion 
release than Ap/RCP scaffolds (Figure 3b). In fact, Ca ion released from MgAp/RCP 
scaffolds was 3 times higher than Ca ion released from Ap/RCP scaffolds. Moreover, 
Ca ion release from Ap/RCP scaffolds seemed to reach a plateau after 28 days of 
soaking while Ca and Mg ion release from MgAp/RCP was still rising at this time point. 
Surprisingly, MgAp/RCP scaffolds showed a higher cumulative Mg ion release 
(7.06±0.07 wt.%) compared to Ca ion (0.16±0.01 wt.%) after 28 days (Figure 3b), 
indicating a faster release of Mg ions compared to Ca ions.  
 
 
 
 
 
 
 
 
Figure 3. (a) Degradation profile of scaffolds after soaking in PBS displayed as weight 
loss respect to immersion time and (b) cumulative ion released from Ap/RCP (pink line) 
and MgAp/RCP (blue line) scaffolds in PBS medium determined by ICP-OES as a 
function of time. Ca2+ ion concentration (wt.% respect to the total Ca content in 
Ap/RCP and MgAp/RCP scaffold) is represented in continuous line (y left axis) 
whereas Mg2+ concentration (wt.% respect to total Mg content in MgAp/RCP scaffold) 
is displayed in dashed line (y right axis). Data are expressed as mean ± SD (n=3). 
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6.3.4. Cell viability and proliferation 
Cell viability was qualitatively assessed after 1 day of cell culture with live/dead assay. 
Figure 4a shows just few dead cells and homogeneous distribution of live cell on the top 
of RCP, Ap/RCP and MgAp/RCP scaffolds indicating good cell seeding and high cell 
viability after 1 day of cell culture. Moreover, cell viability on the three different 
scaffold compositions was quantitatively assessed by MTT assay (Figure 4b). The 
results indicated a significant increase of MSC proliferation over the time for all the 
scaffolds (p<0.001). The rate of MSC proliferation on RCP and MgAp/RCP scaffolds 
was significantly higher than Ap/RCP scaffolds on day 3, 7 and 21 (p<0.01). In detail, 
MgAp/RCP scaffolds showed the highest MSC proliferation at day 7, 14 and 21 of cell 
culture (p<0.01). After 28 days of culture, these differences on MSC proliferation 
disappeared (Figure 4b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Cytocompatibility. (a) Live/dead assay to evaluate cell viability after 1 day of 
cell culture. Live cells in green, dead cells in red on RCP, Ap/RCP and MgAp/RCP 
scaffolds, respectively (Scale bar: 100 µm). (b) Cell viability evaluated by MTT assay 
after 1, 3, 7, 14, 21 and 28 days. Data are expressed as mean ± SEM (n=3). **p<0.01 
and ****p<0.0001. 
 
 
Chapter 6: Fabrication of 3D isotropic scaffolds and their in vitro evaluation	
	
	88 
6.3.5. Cell-material interaction 
MSC adhesion and spreading on the different scaffold compositions after 1 and 7 days 
of culture were analyzed by SEM (Figure 5). After 1 day of cell culture, cells were well 
spread in the top scaffold surface with tight interactions, without significant differences 
among the three groups. However, obvious differences could be observed in terms of 
adhered cell amount and morphology between RCP, Ap/RCP and MgAp/RCP scaffolds 
after 7 days of cell culture. Whereas the number of cells was remarkably larger and the 
cells spread better in RCP and MgAp/RCP scaffolds at the same time point of culture (7 
days), the Ap/RCP scaffolds seemed to promote a detrimental effect on the cell 
adhesion and spreading, as previously observed in MTT analysis (Figure 4b). 
 
 
 
 
 
 
 
 
 
 
Figure 5. SEM images of MSC cells (white arrows) adhered on the top of the scaffold 
surfaces after 1 and 7 days of cell culture. Scale bar: 150 µm. 
 
 
While previous analysis gave an estimation of the cell proliferation over the time (MTT 
assay) and cell distribution at the top surface of the scaffolds (SEM analysis), they did 
not provide information related to the spatial distribution of the cells inside the 
scaffolds. For that purpose, each sample was longitudinally sectioned, cell nuclei were 
stained with DAPI and the inner scaffold surface was scanned in three different areas 
(top, middle and bottom) (Figure 6b). Images of the upper scaffold surface (Figure 6a) 
clearly revealed a larger number of cells in the external part compare to the three 
different inner areas (Figure 6b). Furthermore, MgAp/RCP scaffolds showed a larger 
Chapter 6: Fabrication of 3D isotropic scaffolds and their in vitro evaluation 
 
	 89 
number of cells in the inner part of the scaffold (top, middle and bottom) compared to 
Ap/RCP (p<0.001) and RCP scaffolds (p<0.0001), as indicated in figure 6d. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Cell distribution in the scaffolds after 14 days of cell culture. (a) Microscopic 
images of the upper surface of scaffolds. (b) Microscopic images of three areas from 
inner part of scaffolds (top, middle and bottom). Blue: cell nuclei. Scale bar: 200 µm. 
Graphs display the quantification of the number of cells at the upper surface of the 
scaffolds (c) and in 3 different inner areas of each scaffold. Data are expressed as mean 
± SEM obtained from three different images (n=3). **p<0.01 and ****p<0.0001.  
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6.3.6. Effect of the scaffold on the osteogenic marker expression  
To examine any effect on the expression of the osteogenic markers, induced by the three 
different scaffolds, ascribable to the three types of scaffolds, mRNA level of alkaline 
phosphatase (ALP), osteopontin (OPN) and collagen (Col1) was analyzed by qPCR 
(Figure 7a, b and c, respectively), β-catenin protein expression by western blotting 
(Figure 7d) and the expression of runt-related transcription factor 2 (RUNX-2) by 
immunofluorescence (Figure 8). The results indicated that the ALP expression was up-
regulated in MSCs grown in Ap/RCP and MgAp/RCP and these differences were 
statistically significant compare to RCP (p< 0.001) after 14 days of culture (Figure 7a). 
ALP mRNA level decreased after 28 days of cell culture compared to 14 days. 
However, the significant up-regulation of this gene compared to the RCP was 
maintained (p<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Relative quantification (2-ΔΔCt) of gene expression profiling of ALP (a), OPN 
(b) and COL 1 (c) with respect to the expression of the cells grown on RCP (control), 
using as housekeeping gene GADPH, after 14 and 28 days. (d) Western blot analysis of 
β-catenin expression in comparison with β-actin (loaded as a control) after 14 and 28 
days of cell culture. Data are expressed as mean ± SEM (n=3). *p< 0.05; ** p< 0.01, 
***p<0.001 and ****p<0.0001.  
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The same trend was observed in OPN expression; in fact, MSCs cultured for 14 days on 
Ap/RCP and MgAp/RCP scaffolds displayed a significant increase of OPN mRNA 
level compared to RCP scaffolds (p< 0.05 and p< 0.01, respectively) (Figure 7b). The 
level of this gene remained unvaried after 28 days in the cells growing on Ap/RCP 
scaffolds while showed a significant up-regulation in cells cultured in MgAp/RCP 
scaffolds compared to RCP and Ap/RCP ones (p<0.0001). No differences were found in 
the Col1 expression of MSCs cultured in RCP, Ap/RCP and MgAp/RCP scaffolds at 
both time points (Figure 7c). Western blot analysis (Figure 7d) demonstrated that MSCs 
cultured for 28 days onto MgAp/RCP scaffolds induced significantly higher expression 
of β-catenin levels compare to MSCs cultured onto RCP and Ap/RCP scaffolds (p<0.01 
and p<0.05, respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Representative immunofluorescence images of MSCs cells after 14 days on 
the three different scaffold composition. RUNX-2 in red and cell nuclei in blue. Scale 
bar: 50 µm. 
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In addition, the immunofluorescent evaluation of RUNX-2 after 14 days of cell culture 
might indicate a higher amount of this osteogenic marker in MSCs cultured on 
MgAp/RCP than Ap/RCP and RCP scaffolds (Figure 8). 
 
6.4. Discussion 
In bone tissue regeneration, the interactions of bone substitutes with the host tissue play 
a key role in the regeneration process. In detail, its surface could enhance cell adhesion 
and/or osteogenic differentiation and often lead to an improvement of transplantation 
efficiency.19 Current challenges in bone tissue regeneration include the engineering of 
scaffolds with new levels of biofunctionality that attempt to recreate nanoscale 
topographical and biofactor cues from bone extra cellular matrix (ECM). In this work, 
3D isotropic hybrid scaffolds for bone regeneration were produced by bioinspired 
mineralization of recombinant collagen type I derived peptide (RCP) and further freeze-
drying. By controlling several parameters during freezing, scaffolds with desired porous 
structure were fabricated. The last goal was to demonstrate that biomineralized samples 
enhance cell migration throughout the whole scaffold as well as potentially induce the 
expression of MSC osteogenic markers in vitro. 
By modifying different parameters of freezing protocol, porous structure was optimized. 
For both moulds, teflon and well plate, higher freezing temperature as well as lower 
solid content led to larger pores, as it has been pointed out previously by several 
authors.9,20 Nevertheless, isotropic porous scaffolds with homogeneous structure were 
obtained for scaffolds fabricated by freezing mineralized slurry at -20°C in well plate. 
With these parameters, scaffolds of three different compositions were developed: non-
mineralized (RCP), mineralized (Ap/RCP) and mineralized in the presence of 
magnesium (MgAp/RCP). The three scaffold compositions (RCP, Ap/RCP and 
MgAp/RCP) showed mean pore diameter close to 250 µm that is on the range of pore 
sizes (between 200-350 µm) claimed as the optimum for osteoconduction.21-23 
Moreover, the porosity of designed scaffolds showed similar values to that found in 
cancellous bone (around 75-95%) providing the required space for marrow and blood 
vessels development necessary for bone regeneration.24 Another key factor, correlated 
to the porosity, to consider in the design of tissue-engineered scaffolds is the 
permeability that dictates diffusive transport of cytokines, nutrients, and waste 
throughout the scaffold.25,26 The permeability of bone-like scaffolds designed in this 
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work was higher than the permeability values reported for cancellous bone based upon 
Darcy’s Law,27 indicating a promising in vivo performance of the herein designed 
scaffolds. 
Bioinspired mineralization of natural collagen has been proved to enhance scaffold 
mechanical properties.28 Conversely, in this work, non-mineralized scaffolds showed 
higher young modulus than mineralized ones (Ap/RCP and MgAp/RCP). This effect 
may indicate that the mechanical properties of designed scaffolds do not rely on 
scaffold composition (mineral content), but may rely on other parameters such as 
structure29 or crosslinking extent30,31 of the organic matrix. Considering that the three 
scaffold compositions have similar porosity and pore size, a higher stiffness of RCP 
scaffolds respect to Ap/RCP and MgAp/RCP may be associated to the crosslinking 
extent since RCP scaffolds were endowed with the highest extent of crosslinking 
(Chapter 5). 
As we mentioned above, the main benefit of biomimetic mineralization protocol 
consists in controlling both biophysical and biochemical cues at scaffold interface that 
synergistically regulate the fate of MSCs in vitro or in vivo environment.10,32 Poor 
crystalline apatite was obtained via biomimetic mineralization of RCP due to the 
individual and synergistic effect of the organic matrix (Ap/RCP) and Mg ions 
(MgAp/RCP) on stabilizing the amorphous precursor phase.33 FTIR spectra indicated 
the lower crystallinity of the mineral phase containing in MgAp/RCP scaffolds that can 
promote a higher reactivity under physiological conditions. Previous works that 
evaluated solubility of the mineral phase by electrokinetic studies indicated that both the 
Mg substitution and the B-type carbonation improved the solubility of the apatite 
powder at the physiological pH value (≈7.4).34 Actually, MgAp/RCP scaffolds exhibited 
a faster Ca ion release kinetic when compared to Ap/RCP scaffolds. It has been reported 
that the Ca and Mg ions in culture medium enhance the adhesion and stimulate the 
osteogenic differentiation of cells.10,35-38 Yoshizawa et al.39 demonstrated that hBMSCs 
proliferated faster and they produced more mineralized matrix in vitro due the presence 
of 10 mM MgSO4 in cell culture medium. Concerning Ca, it has been found that Ca 
concentration of 7.8 mM in cell culture medium could enhance the proliferation and the 
up-regulation of osteogenic genes in hMSCs.38 In our studies, enhanced cell growth and 
proliferation was found on MgAp/RCP scaffolds when compared to Ap/RCP and RCP 
scaffolds at day 7, 14 and 21. This effect could be attributed to the Mg ions release from 
the scaffolds that was more than six times higher than the release of Ca ions. 
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Nevertheless, the cell proliferation reached the plateau for all the groups after 28 days 
and did not show statistical differences among them at the end of the experiment. 
In our study, it was also important to identify those scaffolds that best supported cell 
colonization and proliferation within the inner part of the scaffolds since it would be a 
requirement for successful integration in vivo. The in vitro cell culture studies revealed 
that biomimetic mineralization of RCP enhanced the cell-material interaction. In fact, 
MgAp/RCP scaffolds potentially induced cell migration throughout the whole 3D 
scaffold when compared to Ap/RCP and RCP scaffolds. Most of previous works have 
been focused on determining the effect of pore size on cell attachment,20,30 but only 
small number of works have analysed the cell migration throughout the whole 3D 
scaffold.40,41 Since scaffolds exhibited similar pore size and porosity, a greater cell 
migration on MgAp/RCP scaffolds could be related with its physic-chemical surface 
properties. On one hand, the presence of Mg could improve the cell-material interaction 
since it has been previously reported that Mg interacts with osteoblast integrins, which 
are responsible for cell adhesion and stability.35,36 On the other hand, cell-material 
interaction could be enhanced by surface roughness of MgAp/RCP scaffolds which was 
similar to that found in bone (Chapter 4). The main concern of cell migration inside the 
scaffolds is related to the in vivo performance of the scaffolds since the cell distribution 
within the scaffolds has been related to the distribution of tissue subsequently formed 
within engineered constructs,42 suggesting that uniform cell seeding could establish the 
basis for uniform tissue generation. 
Another important indicator of bioactivity is the induction of the expression of genes 
and protein related to the MSC osteogenic commitment, that is on the basis of the bone 
regenerative process.43 The differentiation process towards osteoblasts is regulated by a 
number of key factors and signalling pathways. ALP, which is responsible for the 
mineralization of the ECM,43 OPN, that is the mainly non-collagenous protein of the 
mineralized matrix,44 and RUNX2 which is often referred to as the master switch of 
osteogenic differentiation,45,46 are commonly used as early markers of osteogenic 
differentiation in vitro. In this work a protein and gene expression profile of the cells 
grown in the three different scaffolds were analysed. Our results showed that ALP and 
OPN genes were up-regulated in both Ap/RCP and MgAp/RCP scaffolds compared to 
RCP after 14 days of culture, indicating that the physic-chemical features of the scaffold 
provided by the presence of biomimetic apatite play an important role in the regulation 
of MSC fate, as previously demonstrated on in vitro studies of hydroxyapatite 
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nanocrystals.47 Moreover, MSCs cultured for 28 days in MgAp/RCP scaffolds lead to 
an increase of OPN mRNA and β-catenin protein expression, considered an important 
factor involved in the signalling pathways that promotes MSC differentiation and 
osteoblast activity.48 These results highlighted the key role of interfacial properties 
(chemical and physical cues) of scaffolds on cell migration and the greatest potential of 
MgAp/RCP scaffolds inducing MSC osteogenic differentiation in vitro. 
6.5. Conclusions 
In this work, 3D scaffolds for bone regeneration were synthesized by bioinspired 
mineralization of recombinant collagen type I derived peptide (RCP) and further freeze-
drying. By controlling several freezing parameters such as freezing temperature and 
solid content and also by using different moulds, we can obtain anisotropic or isotropic 
structures with different pore sizes. 3D isotropic porous scaffolds differing on chemical 
composition (RCP, Ap/RCP and MgAp/RCP) but with similar mean pore size (250 
µm), porosity (close to 90%) and great permeability were designed through optimized 
freeze-drying protocol. Mineralized scaffolds showed a better cell migration in the inner 
areas of scaffold compared to non-mineralized scaffolds as well as displayed excellent 
potential for improving the expression of osteogenic markers of MSCs, which was 
reflected by a series of in vitro assays both on the cellular and molecular levels. 
Magnesium incorporation during mineralization protocol (MgAp/RCP) actually 
heightens the cell migration and osteogenic potential of designed scaffolds. Thus, this 
work indicates a promising approach for the development of high quality bone grafts 
with smart interfaces through biomimetic mineralization of synthetic engineering 
peptides and the optimized freeze-drying protocol.  
References 
1. Tsuruga, E., Takita, H., Itoh, H., Wakisaka, Y. and Kuboki, Y. Pore size of 
porous hydroxyapatite as the cell-substratum controls BMP-induced 
osteogenesis. The journal of biochemistry 121, 317, 1997. 
2. y Leon, C.A.L. New perspectives in mercury porosimetry. Adv Colloid Interface 
Sci 76, 341, 1998. 
3. Roy, T.D., Simon, J.L., Ricci, J.L., Rekow, E.D., Thompson, V.P. and Parsons, 
J.R. Performance of degradable composite bone repair products made via three-
dimensional fabrication techniques. J Biomed Mater Res A 66, 283, 2003. 
4. Kuboki, Y., Takita, H., Kobayashi, D., Tsuruga, E., Inoue, M., Murata, M., 
Nagai, N., Dohi, Y. and Ohgushi, H. BMP-induced osteogenesis on the surface 
Chapter 6: Fabrication of 3D isotropic scaffolds and their in vitro evaluation	
	
	96 
of hydroxyapatite with geometrically feasible and nonfeasible structures: 
topology of osteogenesis. J Biomed Mater Res 39, 190, 1998. 
5. Correia, C., Bhumiratana, S., Yan, L.-P., Oliveira, A.L., Gimble, J.M., 
Rockwood, D., Kaplan, D.L., Sousa, R.A., Reis, R.L. and Vunjak-Novakovic, 
G. Development of silk-based scaffolds for tissue engineering of bone from 
human adipose-derived stem cells. Acta Biomater 8, 2483, 2012. 
6. Murphy, C.M., Haugh, M.G. and O'Brien, F.J. The effect of mean pore size on 
cell attachment, proliferation and migration in collagen–glycosaminoglycan 
scaffolds for bone tissue engineering. Biomaterials 31, 461, 2010. 
7. Jones, A.C., Arns, C.H., Hutmacher, D.W., Milthorpe, B.K., Sheppard, A.P. and 
Knackstedt, M.A. The correlation of pore morphology, interconnectivity and 
physical properties of 3D ceramic scaffolds with bone ingrowth. Biomaterials 
30, 1440, 2009. 
8. Karageorgiou, V. and Kaplan, D. Porosity of 3D biomaterial scaffolds and 
osteogenesis. Biomaterials 26, 5474, 2005. 
9. Pawelec, K., Husmann, A., Best, S.M. and Cameron, R.E. Ice-templated 
structures for biomedical tissue repair: From physics to final scaffolds. Applied 
Physics Reviews 1, 021301, 2014. 
10. Samavedi, S., Whittington, A.R. and Goldstein, A.S. Calcium phosphate 
ceramics in bone tissue engineering: a review of properties and their influence 
on cell behavior. Acta Biomater 9, 8037, 2013. 
11. Parvizi, M., Plantinga, J.A., van Speuwel-Goossens, C.A., van Dongen, E.M., 
Kluijtmans, S.G. and Harmsen, M.C. Development of recombinant collagen-
peptide-based vehicles for delivery of adipose-derived stromal cells. J Biomed 
Mater Res A 104, 503, 2016. 
12. Koutsopoulos, S. Synthesis and characterization of hydroxyapatite crystals: A 
review study on the analytical methods. J Biomed Mater Res 62, 600, 2002. 
13. Termine, J.D. and Posner, A.S. Infra-red determination of the percentage of 
crystallinity in apatitic calcium phosphates. 1966. 
14. Morris, M.D. and Finney, W.F. Recent developments in Raman and infrared 
spectroscopy and imaging of bone tissue. Spectroscopy 18, 155, 2004. 
15. Antonakos, A., Liarokapis, E. and Leventouri, T. Micro-Raman and FTIR 
studies of synthetic and natural apatites. Biomaterials 28, 3043, 2007. 
16. Gómez-Morales, J., Iafisco, M., Delgado-López, J.M., Sarda, S. and Drouet, C. 
Progress on the preparation of nanocrystalline apatites and surface 
characterization: Overview of fundamental and applied aspects. Prog Cryst 
Growth Ch 59, 1, 2013. 
17. Deville, S. and Bernard-Granger, G. Influence of surface tension, osmotic 
pressure and pores morphology on the densification of ice-templated ceramics. J 
Eur Ceram Soc 31, 983, 2011. 
18. Jung, H.-D., Yook, S.-W., Kim, H.-E. and Koh, Y.-H. Fabrication of titanium 
scaffolds with porosity and pore size gradients by sequential freeze casting. 
Mater Lett 63, 1545, 2009. 
19. Petrie, T.A., Raynor, J.E., Reyes, C.D., Burns, K.L., Collard, D.M. and García, 
A.J. The effect of integrin-specific bioactive coatings on tissue healing and 
implant osseointegration. Biomaterials 29, 2849, 2008. 
20. O’Brien, F.J., Harley, B.A., Yannas, I.V. and Gibson, L.J. The effect of pore 
size on cell adhesion in collagen-GAG scaffolds. Biomaterials 26, 433, 2005. 
Chapter 6: Fabrication of 3D isotropic scaffolds and their in vitro evaluation 
 
	 97 
21. Whang, K., Healy, K., Elenz, D., Nam, E., Tsai, D., Thomas, C., Nuber, G., 
Glorieux, F., Travers, R. and Sprague, S. Engineering bone regeneration with 
bioabsorbable scaffolds with novel microarchitecture. Tissue Eng 5, 35, 1999. 
22. Klawitter, J. and Hulbert, S. Application of porous ceramics for the attachment 
of load bearing internal orthopedic applications. J Biomed Mater Res 5, 161, 
1971. 
23. Schwartz, I., Robinson, B.P., Hollinger, J.O., Szachowicz, E.H. and Brekke, J. 
Calvarial bone repair with porous D, L-polylactide. Otolaryngology--Head and 
Neck Surgery 112, 707, 1995. 
24. Palmer, L.C., Newcomb, C.J., Kaltz, S.R., Spoerke, E.D. and Stupp, S.I. 
Biomimetic Systems for Hydroxyapatite Mineralization Inspired By Bone and 
Enamel. Chem Rev 108, 4754, 2008. 
25. Agrawal, C.M., McKinney, J.S., Lanctot, D. and Athanasiou, K.A. Effects of 
fluid flow on the in vitro degradation kinetics of biodegradable scaffolds for 
tissue engineering. Biomaterials 21, 2443, 2000. 
26. Caliari, S.R. and Harley, B.A. The effect of anisotropic collagen-GAG scaffolds 
and growth factor supplementation on tendon cell recruitment, alignment, and 
metabolic activity. Biomaterials 32, 5330, 2011. 
27. Kohles, S.S., Roberts, J.B., Upton, M.L., Wilson, C.G., Bonassar, L.J. and 
Schlichting, A.L. Direct perfusion measurements of cancellous bone anisotropic 
permeability. J Biomech 34, 1197, 2001. 
28. Li, Y., Thula, T.T., Jee, S., Perkins, S.L., Aparicio, C., Douglas, E.P. and 
Gower, L.B. Biomimetic Mineralization of Woven Bone-Like Nanocomposites: 
Role of Collagen Cross-Links. Biomacromolecules 13, 49, 2011. 
29. Henkel, J., Woodruff, M.A., Epari, D.R., Steck, R., Glatt, V., Dickinson, I.C., 
Choong, P.F., Schuetz, M.A. and Hutmacher, D.W. Bone regeneration based on 
tissue engineering conceptions—a 21st century perspective. Bone research 1, 
216, 2013. 
30. Tierney, C.M., Haugh, M.G., Liedl, J., Mulcahy, F., Hayes, B. and O’Brien, F.J. 
The effects of collagen concentration and crosslink density on the biological, 
structural and mechanical properties of collagen-GAG scaffolds for bone tissue 
engineering. J Mech Behav Biomed Mater 2, 202, 2009. 
31. Haugh, M.G., Murphy, C.M., McKiernan, R.C., Altenbuchner, C. and O'Brien, 
F.J. Crosslinking and mechanical properties significantly influence cell 
attachment, proliferation, and migration within collagen glycosaminoglycan 
scaffolds. Tissue Engineering Part A 17, 1201, 2011. 
32. Xu, K., Chen, W., Hu, Y., Shen, X., Xu, G., Ran, Q., Mu, C., Yu, Y. and Cai, K. 
Influence of strontium ions incorporated nanosheet-pore topographical titanium 
substrates on osteogenic differentiation of mesenchymal stem cells in vitro and 
osseointegration in vivo. Journal of Materials Chemistry B 2016. 
33. Ramírez-Rodríguez, G.B., Delgado-López, J.M., Iafisco, M., Montesi, M., 
Sandri, M., Sprio, S. and Tampieri, A. Biomimetic mineralization of 
recombinant collagen type I derived protein to obtain hybrid matrices for bone 
regeneration. J Struct Biol 2016. 
34. Landi, E., Logroscino, G., Proietti, L., Tampieri, A., Sandri, M. and Sprio, S. 
Biomimetic Mg-substituted hydroxyapatite: From synthesis to in vivo 
behaviour. J Mater Sci Mater Med 19, 239, 2008. 
35. Zreiqat, H., Howlett, C., Zannettino, A., Evans, P., Schulze-Tanzil, G., Knabe, 
C. and Shakibaei, M. Mechanisms of magnesium-stimulated adhesion of 
Chapter 6: Fabrication of 3D isotropic scaffolds and their in vitro evaluation	
	
	98 
osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res 
62, 175, 2002. 
36. Yamasaki, Y., Yoshida, Y., Okazaki, M., Shimazu, A., Uchida, T., Kubo, T., 
Akagawa, Y., Hamada, Y., Takahashi, J. and Matsuura, N. Synthesis of 
functionally graded MgCO3 apatite accelerating osteoblast adhesion. J Biomed 
Mater Res 62, 99, 2002. 
37. Yoshizawa, S., Brown, A., Barchowsky, A. and Sfeir, C. Role of magnesium 
ions on osteogenic response in bone marrow stromal cells. Connect Tissue Res 
55, 155, 2014. 
38. Barradas, A.M., Fernandes, H.A., Groen, N., Chai, Y.C., Schrooten, J., van de 
Peppel, J., van Leeuwen, J.P., van Blitterswijk, C.A. and de Boer, J. A calcium-
induced signaling cascade leading to osteogenic differentiation of human bone 
marrow-derived mesenchymal stromal cells. Biomaterials 33, 3205, 2012. 
39. Yoshizawa, S., Brown, A., Barchowsky, A. and Sfeir, C. Magnesium ion 
stimulation of bone marrow stromal cells enhances osteogenic activity, 
simulating the effect of magnesium alloy degradation. Acta Biomater 10, 2834, 
2014. 
40. Sobral, J.M., Caridade, S.G., Sousa, R.A., Mano, J.F. and Reis, R.L. Three-
dimensional plotted scaffolds with controlled pore size gradients: Effect of 
scaffold geometry on mechanical performance and cell seeding efficiency. Acta 
Biomater 7, 1009, 2011. 
41. Allan, I.U., Tolhurst, B.A., Shevchenko, R.V., Dainiak, M.B., Illsley, M., 
Ivanov, A., Jungvid, H., Galaev, I.Y., James, S.L., Mikhalovsky, S.V. and 
James, S.E. An in vitro evaluation of fibrinogen and gelatin containing cryogels 
as dermal regeneration scaffolds. Biomaterials Science 4, 1007, 2016. 
42. Holy, C.E., Shoichet, M.S. and Davies, J.E. Engineering three-dimensional bone 
tissue in vitro using biodegradable scaffolds: investigating initial cell-seeding 
density and culture period. J Biomed Mater Res 51, 376, 2000. 
43. Granéli, C., Thorfve, A., Ruetschi, U., Brisby, H., Thomsen, P., Lindahl, A. and 
Karlsson, C. Novel markers of osteogenic and adipogenic differentiation of 
human bone marrow stromal cells identified using a quantitative proteomics 
approach. Stem Cell Res 12, 153, 2014. 
44. Aubin, J.E. Regulation of Osteoblast Formation and Function. Rev Endocr 
Metab Disord 2, 81, 2001. 
45. Ducy, P., Schinke, T. and Karsenty, G. The osteoblast: a sophisticated fibroblast 
under central surveillance. Science 289, 1501, 2000. 
46. Deng, Z.-L., Sharff, K.A., Tang, N., Song, W.-X., Luo, J., Luo, X., Chen, J., 
Bennett, E., Reid, R. and Manning, D. Regulation of osteogenic differentiation 
during skeletal development. Front Biosci 13, 2001, 2008. 
47. Montesi, M., Panseri, S., Iafisco, M., Adamiano, A. and Tampieri, A. Effect of 
hydroxyapatite nanocrystals functionalized with lactoferrin in osteogenic 
differentiation of mesenchymal stem cells. J Biomed Mater Res A, n/a, 2014. 
48. Holmen, S.L., Zylstra, C.R., Mukherjee, A., Sigler, R.E., Faugere, M.-C., 
Bouxsein, M.L., Deng, L., Clemens, T.L. and Williams, B.O. Essential role of β-
catenin in postnatal bone acquisition. J Biol Chem 280, 21162, 2005. 
 
 
	
99 
Chapter 7: Expansion and differentiation of hMSCs on 
nanocomposite scaffolds in a bioreactor with mechanical 
stimulus 
 
7.1. Introduction 
The loss or injury of organs or tissues is one of the most frequent and costly problems in 
health care system with dramatic effects on life quality. Conventionally, the damaged 
organ/tissue has been substituted by transplanted organ from another patient. However, 
the donor shortages and increasing number of patients triggered to the origin of a new 
field, tissue engineering (TE). In 1993, Langer and Vacanti1 defined tissue engineering 
as an interdisciplinary field that applies the principles of engineering and life sciences 
toward the development of biological substitutes that restore, maintain, or improve 
tissue function. The typical procedure of a TE approach consists in isolating cells from 
patient, expanding and seeding the cells on synthetic bioresorbable 3D matrices and 
then the cell/scaffold construction is implanted on the defect of the human (Figure 1) 
where the scaffold will degrade to be replaced by the new tissue.  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 1. Representative scheme of the tissue-engineering concept. Reprinted from 
Dvir et al.,2 Copyright (2011), with permission from Nature Publishing Group: Nature 
Nanotechnology. 
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To enhance osteoinductive properties (improve the formation of new tissue), synthetic 
scaffolds have been incorporated with bone marrow stem cells,3,4 drugs and gene 
delivery,5 and different growth factors, such as TGF-β,6 BMP,7 and VEGF.7,8  
Several studies indicated enhancement of bone formation of synthetic bone substitutes 
when the material was seeded with cells before implantation.9,10 Conventional methods 
(e.g., static seeding in Petri dishes) have been used for the cell seeding of 3D scaffolds. 
However, these methodologies yield engineered constructs comprising a thin tissue-like 
layer at the base of the scaffold, due to gravitational settling of the cells.11,12 In addition, 
static cultures are not optimal due to poor nutrient supply and removal of metabolic 
waste. In fact, the mass transport occurs only via diffusion, which is not sufficient to 
support cell survival and proliferation inside the core of large cell/scaffold constructs, 
resulting in necrosis and poor tissue formation. Furthermore, the cell proliferation and 
matrix synthesis at the construct periphery over the culture period impede medium 
diffusion and contribute to the formation of a nutrient gradient that drive cell migration 
towards the substitute borders.13 Static cell culture is far from the in vivo conditions, not 
only for the diffusion inconvenient but also for the lack of mechanical stimulus. Bone 
cells are sensitive to mechanical stimuli, whose integration and conversion into 
intracellular signals play an important role in driving bone remodelling throughout 
lifetime and regeneration during fracture healing.14,15 
To overcome the shortcomings of static cell seeding and culture, bioreactors have been 
proposed for the cultivation of engineered tissues.16 Among the main advantages, 
bioreactors can improve initial cell seeding density and homogeneity11,17 and at the 
same time, bioreactor can permit studies of mass transport of oxygen17-19 and growth 
factors,20,21 hydrodynamic conditions22,23 and physical stimuli24,25 such as dynamic 
compression or cyclic stretch. Bioreactors for in vitro cell culture can be classified in 
several categories: rotating wall vessels, spinner flasks, perfusion bioreactors and 
compression systems.26 The perfusion bioreactors representing the optimal systems to 
support cell viability, increase construct cellularity and deposition of bone matrix, and 
guide maturation of functional tissue. 
Our previous studies of cell seeding and culture of 3D recombinant peptide scaffolds in 
static conditions in a well plate showed several drawbacks such as poor cell migration 
inside of the scaffolds (Chapter 6). Herein, we aimed to demonstrate the suitability of 
3D mineralized recombinant peptide scaffolds for the cell seeding and culture of human 
mesenchymal stem cells (hMSCs) under dynamic conditions in a direct perfusion 
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bioreactor. Our main goal is to evaluate the osteogenic potential of mineralized 
scaffolds in presence of magnesium (MgAp/RCP) respect to non-mineralized ones in a 
real 3D environment. Furthermore, since bioreactor has the possibility to apply a 
mechanical stimulus during cell culture, and as a first attempt, mechanical stimulus was 
applied to MgAp/RCP scaffolds loaded with hMSCs, evaluating their influence on 
hMSC osteogenic differentiation. 
7.2. Methods 
7.2.1. Flow perfusion bioreactor  
The bioreactor system has been developed at Fraunhofer Institute for Interfacial 
Engineering and Biotechnology (Germany). It is composed of a reservoir flask, the 
bioreactor cartridge and a peristaltic pump to deliver the cell culture medium from the 
reservoir flask to the bioreactor cartridge (Figure 2). The scaffolds were sealed with 
silicone tube with an inner diameter 10 mm and this construct was mounted on the 
bioreactor cartridge. This set-up ensures the homogeneous conditions inside the scaffold 
by pressing a silicone tube to the scaffold avoiding the flow of cell culture medium 
outside of the scaffold, through the walls of the silicone tube. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Bioreactor set-up and computational modelling of shear stress due to flow of 
cell medium through a P[LLA-co-CL] scaffold. (A) Bioreactor set-up composed of: 
bioreactor cartridge (1), computer-controlled pump (2), a reservoir flask including air 
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filters (3), a septum for cell seeding (4), an adapter to attach a pressure sensor (5) and a 
rack system that allows easy handling (6). B) A cross section shows the concept of the 
bioreactor cartridge. From an inlet (7), cell culture medium is guided through the 
cylindrical scaffold (8) to an outlet (9). The bioreactor housing (10) pressed a silicone 
tube (11) to the cylinder jacket surface of the scaffold to ensure homogeneous flow 
conditions in the scaffold. Computational modelling depicts the fluid mechanical 
conditions in the bioreactor for sealed (C) and unsealed (D) scaffolds. Reprinted from 
Kleinhans et al.,27 Copyright (2015) with permission of Wiley-VCH Verlag GmbH & 
Co.  
7.2.2. Cell seeding of 3D scaffolds 
Human mesenchymal stem cells (hMSCs) extracted from different patient donors (P57 
and P58) were kindly supplied by Davide Confalonieri (researcher at University 
Hospital of Wurzburg and member of Bio-inspired project). The hMSCs were expanded 
in growth medium composed of MSCGM-CD media (Lonza), 2% fetal calf serum 
(FCS, Lonza), and 1% Pen/Strep at 37 °C in a humidified atmosphere of 5% CO2. 
Culture medium was replaced 3 times a week. Cells were detached from culture flasks 
by trypsinization, centrifuged and resuspended. Cell number and viability were assessed 
with the trypan-blue dye exclusion test. hMSCs passage 4 were used for the 
experiments. Before cell seeding, sterilized scaffolds by autoclave (diameter=10 mm 
and height=10 mm) were pre-incubated overnight with standard cell culture medium 
(1.5 mL). Then, the scaffolds were seeded under static and dynamic conditions inside 
bioreactor in order to evaluate the most suitable cell seeding methodology:  
 
§ Static cell seeding (St): Scaffolds were replaced in a 24-well plate and each one 
was seeded by carefully dropping 100 µL of cell suspension containing 2.0 x 106 
cells onto the upper surface, allowing cell attachment for 90 min at 37 °C with 5% 
CO2. Then, hMSCs were incubated in osteogenic medium (1.5 mL) consisting in 
DMEM High glucose supplemented with 10% (v/v) FCS, 1% (v/v) Pen/Strep, 10 
mM β-glicerofosfato, 50 µg/ml L-ascorbic acid and 100 nM dexamethasone under 
static conditions (37 °C, 5% CO2) for 1 day. 
§ Dynamic cell seeding: Scaffolds were placed in the custom-fit notch of the 
bioreactor. 750 µL of cell suspension containing 2.0 x 106 (D2) or 5.0 x 106 (D5) 
cells were transferred to a 2 mL syringe and was injected air-bubble free through 
the sterile sampling port manually, in a backward-forward cycles to get 
homogeneous distribution of the cells through the whole scaffold. Then, 
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cell/scaffold construction was maintained for 90 min at 37 °C with 5% CO2 to 
allow cell attachment before connecting to pump system for dynamic cell culture. 
To evaluate the three cell seeding methodologies, after one day of cell culture, cell 
viability was determined by MTT assay. It allows evaluating cell distribution in the 
scaffold since the metabolically active cells react with the tetrazolium salt in the MTT 
reagent producing a formazan dye. Then, formazan crystals can be dissolved with 
DMSO and measured the absorbance (at 570 nm) that is directly proportional to the 
number of metabolically active cells (protocol described in Chapter 2). 
7.2.3. Dynamic cell culture 
For dynamic cell culture, 30 mL of osteogenic cell medium was added to the reservoir 
flask and the seeded scaffolds were perfused in the bioreactor for 5 min at 1 mL/min 
each 15 min at 37 °C and 5% CO2. Dynamic cell culture was carried out initially during 
one day in order to evaluate best cell seeding methodology and for 15 days (previous 
cell seeding through D5 methodology) changing cell medium every three days. All the 
cell-handling procedures were performed in a sterile laminar flow hood. 
7.2.4. Mechanical stimulus 
For dynamic cell culture with mechanical stimulus, 30 mL of cell culture medium was 
added to the reservoir flask and the seeded scaffolds (D5 methodology) were perfused 
in the bioreactor for 5 min at 1 mL/min each 15 min for a period of 7 days at 37 °C and 
5% CO2. After one day of cell culture, mechanical stimulus was applied to cell/scaffold 
construction with amplitude 2% and frequency 1 Hz during one hour once per day. 
Culture medium was changed in the middle of the experiment.  
7.3. Results 
7.3.1. Cell seeding of 3D scaffolds 
Before starting dynamic cell culture in bioreactor, two different cell seeding 
methodologies (static vs dynamic) and two cell densities were evaluated. In the static 
seeding method, the cell suspension (containing 2.0 x 106 cells) was seeded at the top of 
RCP and MgAp/RCP scaffolds and after one day of cell culture, most of the cells 
remained at the top of the scaffold, penetrating few microns, as we can observe in 
scaffold images after MTT assay in Figure 3. The static cell seeding also promoted the 
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formation of cellular capsule around the edges of the scaffold (arrows Figure 3). On the 
other hand, scaffolds seeded under dynamic conditions showed a homogeneous cell 
distribution as indicated the purple colour through the whole scaffolds, for both scaffold 
compositions (RCP and MgAp/RCP) and both cell suspension concentrations (2 and 
5x106 cells). RCP and MgAp/RCP scaffolds seeded with 2x106 cells showed areas with 
light colour at the interior of the scaffold whereas scaffolds seeded with 5x106 cells 
were completely in purple colour both inside and outside. The absorbance value 
indicated higher cell viability for scaffolds seeded under dynamic conditions with 5x106 
cells respect to 2x106 cells (p<0.001). For cell seeding with 2x106 cells, scaffolds 
seeded under static conditions showed higher cell viability than dynamic one (p<0.001). 
Conversely, for static cell seeding, most cells were outside of the scaffolds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Cell viability evaluated by MTT assay after 1 day of cell culture on RCP and 
MgAp/RCP scaffolds seeded by three different methodologies: 2x106 hMSCs seeded in 
static conditions (St), 2x106 hMSCs seeded in dynamic conditions (D2) and 5x106 
hMSCs seeded in dynamic conditions (D5). Graph displays absorbance at 570 nm that 
is proportional to metabolic cell activity. Data are expressed as mean ± SEM (n=3, 
technical replicates). **p<0.01 and ***p<0.001. 
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7.3.2. Dynamic cell culture of hybrid recombinant collagen peptide scaffolds  
RCP and MgAp/RCP scaffolds seeded with 5x106 hMSCs were cultured under dynamic 
conditions for 15 days. Then, the experiment was stopped and cell viability as well as 
osteogenic gene expression was evaluated. The colour of the scaffolds after MTT 
analysis indicated a higher hMSCs proliferation on MgAp/RCP scaffolds (Figure 4b) 
compared to RCP scaffolds (Figure 4a). Nevertheless, no statistical difference of 
absorbance value was found (Figure 4c). The figures 4 d and e show representative 
images of the inner area of RCP and MgAp/RCP scaffolds, respectively, where cell 
nuclei appeared stained in blue colour with DAPI. Both scaffolds showed a good cell 
distribution in the inner areas after 15 days of dynamic cell culture.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Cell viability evaluated by MTT analysis after 15 days cell culture under 
dynamic conditions. Images of a piece of RCP (a) and MgAp/RCP (b) scaffolds after 2 
hours of addition of MTT reagent. The graph (c) displays the absorbance value at 570 
nm after treatment of both cell/scaffold constructions in DMSO. Data are expressed as 
mean ± SEM (n=2 cell patient donors). Microscopic images of the inner areas of RCP 
(d) and MgAp/RCP (e) scaffolds after 15 days of cell culture under dynamic conditions. 
Blue: Cell nuclei. Scale bar 50 µm. 
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After 15 days of cell culture under dynamic conditions, we analysed the expression of 
osteogenic markers: alkaline phosphatase (ALP), collagen (Col1a1), osterix (OSX), 
runt-related transcription factor 2 (RUNX2) and bone sialoprotein (BSP) (Figure 5). 
The results indicated that all the evaluated genes were up regulated for hMSCs grown in 
MgAp/RCP scaffolds when compared to the hMSCs grown in the control scaffolds 
(RCP). Col1a1 mRNA level of cells cultured on MgAp/RCP scaffolds was statistically 
significant respect to RCP (p<0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Relative quantification of gene expression of ALP, Col1, OSX, RUNX-2 and 
BSP respect to housekeeping gene (GAPDH) after 15 days of cell culture under 
dynamic conditions. Data are expressed as mean ± SEM (n=2 cell patient donors). 
***p<0.001. 
 
 
7.3.3. Dynamic cell culture of hMSCs in MgAp/RCP with mechanical stimulus 
The second aim is to evaluate the role of mechanical stimulus on osteogenic 
differentiation of hMSCs cultured on MgAp/RCP scaffolds under dynamic conditions. 
5.0 x 106 hMSCs (only from one cell patient donor, preliminary study) were cultured 
under dynamic conditions without (Control) and with mechanical stimulus (Mechanical) 
up to 7 days. 
The influence of mechanical stimulus on matrix production (mineralization) was 
evaluated by alizarin red staining (Figure 6). However, the main drawback of this 
technique is that MgAp/RCP scaffolds contain calcium and that their calcium content 
might be affected after dynamic perfusion of cell medium (also containing calcium) 
without cells. Therefore, to roughly evaluate the in vitro mineralization, MgAp/RCP 
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scaffolds without cells (NC) were cultured for 7 days under dynamic conditions to 
quantify the calcium content of the scaffolds (alone, without cells) after this period. The 
calcium content of cell-loaded scaffolds cultured under dynamic conditions with 
mechanical stimulus (Mechanical) was compared respect to the calcium of cell-loaded 
scaffolds cultured in the same conditions without mechanical stimulus (Control). The 
results indicated a significant increase (p<0.01) of mineralization due to mechanical 
stimulus (Figure 6). Cell-loaded scaffolds cultured with and without mechanical 
stimulus exhibited higher calcium content than scaffolds without cells (p<0.001) that 
could indicate that in vitro mineralization took place in both conditions.  
 
 
 
 
 
 
 
 
Figure 6. Scaffold mineralization after 7 days of cell culture under dynamic conditions 
without (Control) and with mechanical stimulus analysed by Alizarin red staining. 
Graph displays the calcium content measured quantitatively by dissolving alizarin red. 
NC represents calcium content of MgAp/RCP scaffolds after 7 days under dynamic flux 
of cell medium but without cells. Data are expressed as mean ± SEM (n=3 technical 
replicates). ** p<0.01 and ***p < 0.001. 
 
To investigate the influence of mechanical stimulus on osteogenic lineage commitment, 
we evaluated the expression of osteogenic gene markers as well as genes related to 
angiogenesis by qPCR (Figure 7). The genes under study were: secreted protein acidic 
and rich in cysteine (SPARC) known as osteonectin, bone gamma-carboxyglutamic 
acid-containing protein (BGLAP) known as osteocalcin, runt-related transcription factor 
2 (RUNX2), alkaline phosphatase (ALP), collagen (Col1), vascular endothelial growth 
factor (VEGF), transforming growth factor (TGF-β) and bone morphogenetic protein 
(BMP-2). All the genes were up regulated for scaffolds subjected to mechanical 
stimulus respect to the control, except from SPARC and BGLAP expression.  
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Figure 7. Relative quantification of gene expression respect to housekeeping gene 
(GAPDH) of hMSCs cultured on MgAp/RCP scaffolds after 7 days of dynamic cell 
culture without (Control) and with mechanical stimulus (Mechanical). Data are 
expressed as mean ± SEM (n=3 technical replicates). 
 
7.4. Discussion 
Hybrid recombinant collagen peptide scaffolds are proposed for bone tissue engineering 
as a matrix to support hMSCs differentiation and the further formation of new bone. 
However, our previous in vitro studies in static conditions (Chapter 6) showed several 
drawbacks such as poor cell migration to the inner areas of the scaffolds. To overcome 
these shortcomings, herein we proposed to improve 3D cell culture system by working 
in a bioreactor of direct perfusion. The bioreactor technology allows the generation of 
cell-loaded bone substitutes for treatment of critical size bone defects by overcoming 
limitations of nutrients supply when cells are culture in static conditions in a porous 3D 
scaffold.28 Three main issues were explored along this chapter: cell seeding, cell culture 
under dynamic conditions to demonstrate the potential of mineralization of recombinant 
collagen peptide scaffolds on enhancing hMSCs osteogenic differentiation and the 
evaluation of the influence of mechanical stimulus on osteogenic commitment of 
hMSCs cultured on 3D hybrid scaffolds.  
The cell seeding of scaffolds is the first step in establishing a 3D culture, and might play 
a crucial role in determining the progression of tissue formation.29 In fact, seeding cells 
into 3D scaffolds at high densities has been associated with enhanced tissue formation 
in 3D constructs, including higher rates of cartilage matrix production,30 increased bone 
mineralization31 and enhanced cardiac tissue structure.32 Moreover, the initial 
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distribution of cells within the scaffold after seeding has been related to the distribution 
of tissue subsequently formed within engineered constructs,31,33-35 suggesting that 
uniform cell seeding could establish the basis for uniform tissue generation. Some of the 
previous works on 3D cell culture under dynamic conditions have carried out the cell 
seeding in static conditions and later the cell/scaffold construction has been moved to a 
bioreactor to evaluate the cell response respect to different parameters of dynamic cell 
culture.13,36,37 In fact, static cell seeding onto a 3D scaffold is by far the most commonly 
used seeding method. However, several studies reported low seeding efficiencies and 
non-uniform cell distributions within scaffolds.31,33,38-40 Other authors have carried out 
cell seeding and cell culture, both, under dynamic conditions.27,41,42 Herein, we carried 
out cell seeding in static and dynamic conditions. The results indicated a more uniform 
cell distribution, even in the inner areas of the scaffolds, for cell seeding under dynamic 
conditions. It fits with previous studies that indicated higher seeding efficiencies and 
more-uniform cell distributions for 3D-scaffolds seeded by direct perfusion in 
automated bioreactor when compared with either static seeding or the stirred-flask 
bioreactor.13,39,43 Unlike cell culture in static conditions (Chapter 6), the dynamic 
conditions provided a real 3D cell culture environment to evaluate the influence of 
scaffold mineralization in the presence of magnesium (MgAp/RCP scaffolds) in the 
osteogenic differentiation of hMSCs. After 15 days of cell culture under dynamic 
conditions, RCP and MgAp/RCP scaffolds did not show significant difference on cell 
proliferation and distribution. Conversely, hMSCs cultured on MgAp/RCP scaffolds 
showed up-regulation of several markers of osteogenic differentiation in vitro: ALP, 
which is responsible for the mineralization of the ECM,44 Col1 since the mineral 
nucleation begins at the junction between two collagen fibre bundles, OSX which is an 
osteoblast-specific transcription factor which activates a repertoire of genes during 
differentiation of preosteoblasts into mature osteoblasts and osteocytes,45 RUNX2 
which is often referred to as the master switch of osteogenic differentiation46,47 and BSP 
that binds to Ca2+ via free hydroxyl groups and promotes nucleation of mineral.48 The 
results highlighted the greatest potential of MgAp/RCP scaffolds inducing MSCs 
osteogenic differentiation in vitro, both in static (Chapter 6) and dynamic conditions.  
A preliminary test to evaluate the influence of mechanical stimulus on hMSCs cultured 
on hybrid-mineralized scaffolds (MgAp/RCP) was carried out up to 7 days of cell 
culture. The mechanical stimulus promoted the hMSCs osteogenic differentiation (up-
regulation of osteogenic markers) and ECM production (collagen and calcium 
Chapter 7: hMSCs cultured on hybrid scaffolds in a bioreactor  	
	110 
production) when compared with cell/scaffold construction perfused in the bioreactors 
in the same conditions but without mechanical stimulus. The mechanical stimulus also 
promoted the expression of VEGF and TGF-β that play relevant roles in angiogenesis.49 
Mauney et al.50 demonstrated that the mechanical stimulation enhanced alkaline 
phosphatase activity, bone-specific protein transcript levels (alkaline phosphatase and 
osteopontin) and mineralized matrix production of human bone marrow stromal cells 
(BMSCs). The first demonstration that strain alone can induce osteogenic differentiation 
without the addition of osteogenic supplements was reported by Sumanasinghe et al.51 
There are increasing evidence suggesting that mechanical forces, which are known to be 
important modulators of cell physiology, might increase the activity of cells cultured in 
synthetic substitutes and, thus, possibly improve or accelerate tissue regeneration in 
vitro.52 
7.5. Conclusions 
In this chapter, static and dynamic cell seeding methodologies were evaluated. Dynamic 
cell seeding of recombinant collagen peptide scaffolds (RCP and MgAp/RCP) showed 
uniform cell distribution along the inner areas of tested scaffolds. Furthermore, hMSCs 
cultured on MgAp/RCP scaffolds under dynamic conditions in the bioreactor of direct 
perfusion showed up-regulation of osteogenic genes when compared to hMSCs cultured 
on RCP scaffolds under the same conditions. Hence, the mechanical stimulus on cells 
seeded on MgAp/RCP scaffold promoted an enhancement of mineralization as well as 
higher up-regulation of osteogenic genes. To the best of our knowledge, this work 
represents the first study that evaluate the influence of the biomimetic mineralization of 
a recombinant collagen peptide scaffold on the hMSCs behaviour in a bioreactor of flow 
perfusion. Herein, the possibility to enhance osteogenic differentiation thanks to 
mechanical stimulus was also evaluated.  
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  Chapter 8: Concluding remarks 
The need of synthetic bone grafts that recreate from macro to nanoscale level the 
biochemical and biophysical cues of bone extracellular matrix (ECM) has been a major 
driving force for the development of new generation of biomaterials. In this PhD thesis, 
new synthetic bone substitutes have been synthesized via biomimetic mineralization of 
a recombinant collagen type I derived peptide (RCP) enriched in tri-amino acid 
sequence arginine-glycine-aspartate (RGD) and a further freeze-drying. This approach 
synergistically combines the biofunctionality provided by cell binding sites (RGD 
sequences) incorporated in RCP sequence with the bioactivity conferred by 
incorporation of biomimetic mineral phase imitating bone-apatite feature (e.g., 
composition and crystallinity). 
Biomimetic protocol previously applied for mineralization of natural collagen has been 
successfully adapted for RCP mineralization. Magnesium was introduced during 
mineralization to closer mimic bone apatite ionic composition. The first step was the 
investigation of the role of RCP and Mg on mineralization mechanism and final physic-
chemical feature of synthesized apatites (Ap). Poor crystalline Ap nanocrystals were 
obtained in all conditions, together with a certain extent of amorphous calcium 
phosphate (ACP). The thorough characterization of powdered samples indicated the 
simultaneous effect of the RCP and Mg on stabilizing ACP as well as hindering crystal 
growth along c-axis.  
The next step was to develop prototype 3D hybrid scaffolds with increasing mineral 
content in order to determine the maximum amount of mineral phase that can be 
integrated homogeneously into the organic matrix through the biomimetic RCP 
mineralization. Since RCP does not self-assemble into large microfibers and has lower 
density of charged amino acids groups than natural collagen, lower mineral integration 
than natural bone might be expected. In fact, powdered samples or brittle and 
heterogeneous scaffolds were obtained for higher mineral contents (50-70 wt.%). On the 
other hand, prototype scaffolds with homogeneous composition were synthesized for 60 
wt.% of organic phase and 40 wt.% of mineral phase. For this composition, mineralized 
matrices were developed in the presence and in the absence of magnesium. The 
presence of Mg during RCP mineralization provided hybrid matrices with homogeneous 
mineral distribution at nanoscopic level and mean surface roughness similar to that 
found in bone. 
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Since RCP is water soluble, two crosslinking techniques (genipin and dehydrothermal 
crosslinking, DHT) were investigated to ensure scaffold stability under physiological 
condition. The chemical crosslinking with genipin was set-up by immersion of the RCP 
scaffolds in genipin in aqueous-ethanol solution and the genipin concentration was 
selected considering the crosslinking degree and the water uptake capacity of RCP 
scaffolds. Then, the two crosslinking methodologies were applied to the three scaffold 
compositions under study: non-mineralized (RCP) and mineralized in the absence 
(Ap/RCP) and in the presence of Mg (MgAp/RCP). Crosslinked scaffolds either by 
genipin or DHT showed a good stability under physiological conditions up to 28 days. 
The results indicated that the presence of the mineral phase might hinder the 
crosslinking reaction (lower crosslinking extent for mineralized scaffolds). While the 
highest extent of crosslinked was achieved for scaffolds crosslinked with genipin 
(independently of the scaffold composition), the scaffolds crosslinked by DHT were 
endowed with a higher enzymatic resistance and therefore, they were selected for the 
further in vitro tests.  
The next goal was to tailor and design 3D isotropic porous scaffold by freeze-drying 
through the investigation of several freezing parameters such as solid content, mould 
and freezing temperature. Isotropic porous structures with pore size suitable for cell 
proliferation were obtained by freezing mineralized slurry in a well plate at -20 °C. The 
three scaffold compositions (RCP, Ap/RCP and MgAp/RCP) showed similar porous 
structure with mean pore size 250 µm, porosity close to 90% and great permeability. 
Then, mouse mesenchymal stem cells (MSCs) were cultured on the 3D isotropic 
scaffolds in static conditions to investigate the cytocompatibility and osteogenic 
potential of designed scaffolds. Mineralized scaffolds showed a better cell migration in 
the inner areas of the scaffold compared to non-mineralized scaffolds as well as 
displayed excellent potential for improving the expression of osteogenic markers of 
MSCs. Magnesium incorporation during mineralization protocol (MgAp/RCP) actually 
heightened the cell migration and osteogenic potential of designed scaffolds. 
Finally, RCP and MgAp/RCP scaffolds were tested in vitro under dynamic conditions 
in a bioreactor of direct perfusion (developed at Fraunhofer Institute) in order to ensure 
a real 3D culture state. Dynamic cell seeding of RCP and MgAp/RCP scaffolds showed 
uniform cell distribution along the inner areas of the tested scaffolds after one day of 
cell culture. Human mesenchymal stem cells (hMSCs) cultured on MgAp/RCP 
scaffolds under dynamic conditions up to 15 days showed up-regulation of osteogenic 
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markers when compared to hMSCs cultured on RCP scaffolds in the same conditions. 
Furthermore, a preliminary test consisting in applying mechanical stimulus to hMSCs 
seeded on MgAp/RCP scaffolds indicated that mechanical stimulus might promote an 
enhancement of mineralization as well as higher up-regulation of osteogenic genes.  
The results obtained and reported herein indicate that biomimetic mineralization of 
recombinant collagen peptide in the presence of magnesium is a promising approach for 
the development of high quality bone grafts with smart interfaces that promote cell-
material interaction and osteogenic differentiation of mesenchymal stem cells. 
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